Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk
Open accessAbstract
Chlamydia pneumoniae is a respiratory tract pathogen but can also infect the central nervous system (CNS). Recently, the link between C. pneumoniae CNS infection and late-onset dementia has become increasingly evident. In mice, CNS infection has been shown to occur weeks to months after intranasal inoculation. By isolating live C. pneumoniae from tissues and using immunohistochemistry, we show that C. pneumoniae can infect the olfactory and trigeminal nerves, olfactory bulb and brain within 72 h in mice. C. pneumoniae infection also resulted in dysregulation of key pathways involved in Alzheimer’s disease pathogenesis at 7 and 28 days after inoculation. Interestingly, amyloid beta accumulations were also detected adjacent to the C. pneumoniae inclusions in the olfactory system. Furthermore, injury to the nasal epithelium resulted in increased peripheral nerve and olfactory bulb infection, but did not alter general CNS infection. In vitro, C. pneumoniae was able to infect peripheral nerve and CNS glia. In summary, the nerves extending between the nasal cavity and the brain constitute invasion paths by which C. pneumoniae can rapidly invade the CNS likely by surviving in glia and leading to Aβ deposition.
AI snapshot
Written from the paper’s full text.
TL;DR
Intranasally inoculated *Chlamydia pneumoniae* rapidly infects the olfactory and trigeminal nerves, olfactory bulb, and brain in mice within 72 h, without detectable blood infection. Infection is associated with local amyloid beta deposition and longer-term dysregulation of Alzheimer’s disease–related gene pathways.
Key findings
- Infectious *C. pneumoniae* was isolated from olfactory mucosa, olfactory bulb, trigeminal nerve, and brain at 3 and 7 days post intranasal inoculation; no *C. pneumoniae* was detected in vehicle controls, and PCR showed no *C. pneumoniae* in blood at 2, 3, or 4 days.
- Nasal epithelial injury increased *C. pneumoniae* load in olfactory mucosa at days 3 and 7, olfactory bulb, and trigeminal nerve at day 7, but did not significantly alter load in the brain beyond the bulb.
- *C. pneumoniae* inclusions in olfactory nerve and bulb were associated with localized Aβ deposits at 3, 7, and 28 days; control mice showed only diffuse/patchy Aβ immunolabelling.
- NanoString Alzheimer’s disease panel analysis found 514 genes up-regulated at day 7 versus 232 at day 28, and 53 genes differentially regulated between day 28 and day 7 (22 down, 31 up); 10 REACTOME pathways were significant at p < 0.05, mostly down-regulated at day 28.
Methods
- 7–8 week old female BALB/c mice were intranasally inoculated with *C. pneumoniae* AR39 (1 × 10⁶ IFU/mouse, N = 12) or PBS vehicle (N = 5), with or without methimazole-induced nasal epithelial injury, and sacrificed at 1, 3, 7, or 28 days.
- Viable bacteria were quantified by organ load assay on HEp-2 cells as inclusion-forming units (IFU/mL); blood was tested by 16S rRNA qPCR; tissues were examined by immunohistochemistry for *C. pneumoniae* and Aβ.
- Primary mouse olfactory ensheathing cells, trigeminal Schwann cells, astrocytes, and microglia were infected at MOI 1:1 for 72 h; brain RNA from infected and control mice (N = 3/group) was analyzed with NanoString nCounter Alzheimer’s disease panel, with ANOVA and Benjamini–Hochberg adjustment.
Limitations
- The paper states that *C. pneumoniae* inclusions and associated Aβ deposits were sporadic, so Aβ levels could not be quantified across time points or between infected and control animals.
- The paper states that definitive *C. pneumoniae* inclusions were not found in brain tissue beyond the olfactory bulb by histology, though viable bacteria were isolated from that tissue.
- Evident from the text: findings are from wild-type mice and primary mouse glial cultures, not human brains or Alzheimer’s disease mouse models; gene expression data used N = 3/group, and the study shows association rather than causation for Alzheimer’s disease pathogenesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
76 of 107 cited sources checked · 36 supported · 1 flagged · accuracy not yet measured
- Premisecitation
C. pneumoniae DNA was found in 80% of patient brains, compared to 11% of control brains.
“More recently, C. pneumoniae DNA was found in 80% of patient brains, compared to 11% of control brains11.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [11] Gerard, H. C. et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain. FEMS Immunol. Med. Microbiol. 48, 355–366. https://doi.org/10.1111/j.1574-695X.2006.00154.x (2006). source
- Premisecitation
The olfactory bulb, entorhinal cortex and hippocampal formation (all olfactory structures), as well as the brainstem, are the CNS regions that exhibit the earliest signs of pathology in both late-onset dementia and familial Alzheimer's disease.
“Interestingly, the olfactory bulb, entorhinal cortex and hippocampal formation (all olfactory structures), as well as the brainstem, are the CNS regions that exhibit the earliest signs of pathology in both late-onset dementia and familial Alzheimer’s disease21–23.”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [21] Mann, D. M., Tucker, C. M. & Yates, P. O. Alzheimer’s disease: An olfactory connection?. Mech. Ageing Dev. 42, 1–15. https://doi.org/10.1016/0047-6374(88)90058-9 (1988). source
- cites [22] Murphy, C. Olfactory and other sensory impairments in Alzheimer disease. Nat. Rev. Neurol. 15, 11–24. https://doi.org/10.1038/s41582-018-0097-5 (2019). source
- cites [23] Simic, G. et al. Does Alzheimer’s disease begin in the brainstem?. Neuropathol. Appl. Neurobiol. 35, 532–554. https://doi.org/10.1111/j.1365-2990.2009.01038.x (2009). source
The section on early dorsal raphe nucleus involvement (page not provided) describes early brainstem pathology and proposes a sequence from the dorsal raphe nucleus to the entorhinal cortex and hippocampal formation. It does not establish the olfactory bulb as an earliest-affected region or establish this regional sequence for both late-onset dementia and familial Alzheimer’s disease. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
C. pneumoniae has been linked to late-onset dementia (late-onset Alzheimer's disease).
“C. pneumoniae primarily infects the pulmonary and nasal mucosa, but has in recent years been linked to diseases distinct from the respiratory tract, such as atherosclerosis/coronary disease3, asthma4, inflammatory arthritis5, multiple sclerosis6 and, in particular, late-onset dementia (late-onset Alzheimer’s disease)7,8.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [7] Balin, B. J. et al. Chlamydia pneumoniae: An etiologic agent for late-onset dementia. Front. Aging Neurosci. 10, 302. https://doi.org/10.3389/fnagi.2018.00302 (2018). source
- cites [8] Itzhaki, R. F. et al. Microbes and Alzheimer’s disease. J. Alzheimer’s Dis. 51, 979–984. https://doi.org/10.3233/JAD-160152 (2016). source
- Premisecitation
Viable C. pneumoniae bacteria have been isolated from some post-mortem patient brains.
“Viable C. pneumoniae bacteria have also been isolated from some post-mortem patient brains7.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [7] Balin, B. J. et al. Chlamydia pneumoniae: An etiologic agent for late-onset dementia. Front. Aging Neurosci. 10, 302. https://doi.org/10.3389/fnagi.2018.00302 (2018). source
- Premisecitation
The nerves that extend between the nasal cavity and the brain, the olfactory and trigeminal nerves, have been shown to be a path for CNS infection by some infectious agents.
“The nerves that extend between the nasal cavity and the brain, the olfactory and trigeminal nerves, have been shown to be a path for CNS infection by some infectious agents reviewed in20.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [20] Dando, S. J. et al. Pathogens penetrating the central nervous system: Infection pathways and the cellular and molecular mechanisms of invasion. Clin. Microbiol. Rev. 27, 691–726. https://doi.org/10.1128/CMR.00118-13 (2014). source
- Premisecitation
C. pneumoniae DNA in the olfactory mucosa and olfactory bulb has been detected 1 week after inoculation.
“After intranasal inoculation in mice, C. pneumoniae antigens and/or infectious organisms have been detected in the olfactory mucosa and the olfactory bulb 1–4 months post intranasal inoculation16–18, and C. pneumoniae DNA in these tissues has been detected 1 week after inoculation18, strongly suggesting that the bacteria can infect the CNS via the olfactory nerve.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
The Results section reports C. pneumoniae DNA in the olfactory bulbs of infected mice one week after inoculation. The Methods section lists the brain regions tested but does not include the olfactory mucosa, so this source does not support the claim of detection in both tissues. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
After intranasal inoculation in mice, C. pneumoniae antigens and/or infectious organisms have been detected in the olfactory mucosa and the olfactory bulb 1-4 months post intranasal inoculation.
“After intranasal inoculation in mice, C. pneumoniae antigens and/or infectious organisms have been detected in the olfactory mucosa and the olfactory bulb 1–4 months post intranasal inoculation16–18, and C. pneumoniae DNA in these tissues has been detected 1 week after inoculation18, strongly suggesting that the bacteria can infect the CNS via the olfactory nerve.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [16] Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces alzheimer’s-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25, 419–429. https://doi.org/10.1016/S0197-4580(03)00127-1 (2004). source
- cites [17] Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). source
The Results section (page unavailable) reports C. pneumoniae antigen in olfactory bulbs at 1 and 3 months and viable organisms in olfactory bulbs at 1, 3, and 4 months after intranasal infection. It does not report detection in the olfactory mucosa, so that part of the attributed claim is unsupported. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
The Discussion (page unavailable) reports that Little et al. detected C. pneumoniae in infected mice’s olfactory tissues up to 3 months after inoculation. This paper’s own Results found C. pneumoniae DNA in the olfactory bulb at 1 week, but not at 1 or 3 months; it does not establish detection of antigens or infectious organisms in both named tissues at 1–4 months. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingown data
Control uninfected mice exhibited diffuse Aβ deposits.
“while control uninfected mice exhibited diffuse Aβ deposits (Fig. 5P) which is similar to previous reports16,18,50.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [16] Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces alzheimer’s-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25, 419–429. https://doi.org/10.1016/S0197-4580(03)00127-1 (2004). source
- cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
- cites [50] Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). source
The Results section (‘Identification and distribution of amyloid antigen in the central nervous system’; page unavailable) reports a low but detectable number of amyloid-immunoreactive sites in mock-infected control mice at 2, 3, and 4 months. It does not describe those deposits as diffuse, so it supports their presence but not the claimed morphology. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Interpretationown data
The time-frame for infection of the CNS by C. pneumoniae was considerably faster than what has previously been shown (1 week-3 months).
“The time-frame for infection of the CNS by C. pneumoniae was considerably faster than what has previously been shown (1 week–3 months16–18)”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [16] Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces alzheimer’s-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25, 419–429. https://doi.org/10.1016/S0197-4580(03)00127-1 (2004). source
- cites [17] Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). source
The Results sections report C. pneumoniae antigen in the brain at one month after infection and viable organisms in the olfactory bulbs at one and three months; viable organisms were recovered from cerebral tissue in one mouse at three months. The paper does not report CNS infection at one week, so it supports the months-long portion of the cited range but not its one-week endpoint. No page number is available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
- Premisecitation
C. pneumoniae antigens have been detected inside both astrocytes and microglia in post-mortem human brains.
“C. pneumoniae antigens have been detected inside both astrocytes and microglia in post-mortem human brains9,11,67,68.”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [9] Balin, B. J. et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med. Microbiol. Immunol. 187, 23–42. https://doi.org/10.1007/s004300050071 (1998). source
- cites [11] Gerard, H. C. et al. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain. FEMS Immunol. Med. Microbiol. 48, 355–366. https://doi.org/10.1111/j.1574-695X.2006.00154.x (2006). source
- cites [67] Hammond, C. J. et al. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer’s disease brain. BMC Neurosci. 11, 121. https://doi.org/10.1186/1471-2202-11-121 (2010). source
The Results (page not available) report intracellular C. pneumoniae antigen labeling in neuroglia in human Alzheimer’s disease brain tissue. They do not identify the labeled neuroglia separately as both astrocytes and microglia. The Background says those cell types are susceptible to infection, but that does not establish antigen detection inside each in the examined brains. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [68] Arking, E. J. et al. Ultrastructural analysis of Chlamydia pneumoniae in the Alzheimer’s brain. Pathogenesis (Amst) 1, 201–211 (1999).
- Premisecitation
Experimental injuries to the nasal epithelium of mice have been shown to increase the risk of bacterial invasion of the olfactory nerve and bulb by some bacteria.
“Experimental injuries to the nasal epithelium of mice has been shown to increase the risk of bacterial invasion of the olfactory nerve and bulb by some bacteria27,28.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [27] Walkden, H. et al. Burkholderia pseudomallei invades the olfactory nerve and bulb after epithelial injury in mice and causes the formation of multinucleated giant glial cells in vitro. PLoS Negl. Trop. Dis. 14, e0008017. https://doi.org/10.1371/journal.pntd.0008017 (2020). source
- cites [28] Herbert, R. P. et al. Cytokines and olfactory bulb microglia in response to bacterial challenge in the compromised primary olfactory pathway. J. Neuroinflamm. 9, 109. https://doi.org/10.1186/1742-2094-9-109 (2012). source
- Premisecitation
Previous studies have shown that Aβ accumulation after C. pneumoniae inoculation occurs after months.
“Whilst previous studies have shown that this occurs after months16–18, if the bacteria reach the CNS more rapidly, alterations in Aβ deposition may also occur sooner.”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [16] Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces alzheimer’s-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25, 419–429. https://doi.org/10.1016/S0197-4580(03)00127-1 (2004). source
- cites [17] Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). source
- cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
The Results summarized in the paper report extracellular Aβ immunoreactivity at 1 and 3 months after C. pneumoniae inoculation. However, the Discussion says similar immunoreactivity occurred in mock-infected and untreated mice, so this study does not establish that inoculation caused Aβ accumulation. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
One key mechanism is thought to be the ability of certain pathogens to infect and survive in OECs, TgSCs and astrocytes, as well as in microglia.
“Whilst it is largely unknown why certain infectious agents can infect the CNS via cranial nerves, one key mechanism is thought to be the ability of these pathogens to infect and survive in OECs, TgSCs and astrocytes, as well as in microglia (the main phagocytes inside CNS tissue)20,27,28,34,35.”
Quote in the paperSubstantial claim5 of 5 sources checked- cites [20] Dando, S. J. et al. Pathogens penetrating the central nervous system: Infection pathways and the cellular and molecular mechanisms of invasion. Clin. Microbiol. Rev. 27, 691–726. https://doi.org/10.1128/CMR.00118-13 (2014). source
In “Pathogens That Enter the Brain Through the Nose: Bacteria” (p. 18), the review proposes that bacteria may travel along olfactory or trigeminal nerves within surrounding olfactory ensheathing cells or Schwann cells. Its Concluding Remarks (p. 22) say whether bacteria travel within the glia remains unanswered. The cited passages do not establish pathogen survival in those cells or identify infection and survival in astrocytes and microglia as part of this mechanism. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [27] Walkden, H. et al. Burkholderia pseudomallei invades the olfactory nerve and bulb after epithelial injury in mice and causes the formation of multinucleated giant glial cells in vitro. PLoS Negl. Trop. Dis. 14, e0008017. https://doi.org/10.1371/journal.pntd.0008017 (2020). source
The Results section (page unavailable) reports that B. pseudomallei infected OECs and TgSCs in vitro, and the Discussion says only some of those cells appeared to degrade the bacteria. The paper does not establish infection and survival in astrocytes or microglia as this mechanism; its Discussion instead describes astrocytes as a defence barrier that can partially degrade the bacteria. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [28] Herbert, R. P. et al. Cytokines and olfactory bulb microglia in response to bacterial challenge in the compromised primary olfactory pathway. J. Neuroinflamm. 9, 109. https://doi.org/10.1186/1742-2094-9-109 (2012). source
The Discussion section, “Infiltration of bacteria in the primary olfactory pathway” (page unavailable), suggests that OECs could act as hosts for invading bacteria. It does not establish pathogen survival in OECs or identify TgSCs, astrocytes, and microglia as cells in which pathogens infect and survive. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [34] Macedo-Ramos, H. et al. Olfactory ensheathing cells as putative host cells for Streptococcus pneumoniae: Evidence of bacterial invasion via mannose receptor-mediated endocytosis. Neurosci. Res. 69, 308–313. https://doi.org/10.1016/j.neures.2010.12.015 (2011). source
Section 3.3 reports that Streptococcus pneumoniae entered cultured OECs, and the Discussion proposes that OECs could carry bacteria along an olfactory route into the CNS. The paper does not establish pathogen survival inside OECs; it also does not test infection or survival in TgSCs, astrocytes, or microglia. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [35] Delbaz, A. et al. Neisseria meningitidis induces pathology-associated cellular and molecular changes in trigeminal schwann cells. Infect. Immun. https://doi.org/10.1128/IAI.00955-19 (2020). source
The Discussion (page unavailable) reports that N. meningitidis infected trigeminal Schwann cells and proposes this as a possible route to the CNS. The Introduction also describes other pathogens surviving within Schwann cells. This paper does not establish the claimed mechanism across OECs, astrocytes and microglia, or demonstrate that N. meningitidis survives within trigeminal Schwann cells. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Aβ secretion in response to pathogens by (wild-type) neural cells can be rapid.
“Whilst Aβ deposition is of course much more pronounced in Alzheimer’s disease mouse models, Aβ secretion in response to pathogens by (wild-type) neural cells can be rapid12.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [12] Soscia, S. J. et al. The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505. https://doi.org/10.1371/journal.pone.0009505 (2010). source
The Discussion proposes that infection could stimulate an innate immune response and subsequent Aβ production in the CNS. It does not report rapid Aβ secretion by wild-type neural cells in response to pathogens; that specific timing and cell-level claim is unsupported. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
Most microbes are likely eliminated by phagocytic glia, olfactory ensheathing cells (OECs) and trigeminal Schwann cells (TgSCs), should they penetrate the epithelium and reach the nerves.
“Most microbes are, however, likely eliminated by phagocytic glia, olfactory ensheathing cells (OECs) and trigeminal Schwann cells (TgSCs), should they penetrate the epithelium and reach the nerves29–31.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [29] Nazareth, L. et al. Olfactory ensheathing cells are the main phagocytic cells that remove axon debris during early development of the olfactory system. J. Comp. Neurol. 523, 479–494. https://doi.org/10.1002/cne.23694 (2015). source
The section ‘OECs are the main phagocytic cell during early development’ (page not provided) reports that OECs can phagocytose bacteria in vitro. ‘Morphology changes after widespread degeneration’ says OECs could phagocytose invading bacteria, but also describes how bacteria can evade them and migrate toward the brain. The paper does not establish that most microbes reaching the nerves are eliminated, or that trigeminal Schwann cells eliminate them. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [30] Nazareth, L. et al. Differing phagocytic capacities of accessory and main olfactory ensheathing cells and the implication for olfactory glia transplantation therapies. Mol. Cell Neurosci. 65, 92–101. https://doi.org/10.1016/j.mcn.2015.03.005 (2015). source
The Discussion identifies OECs as the main phagocytic cells of olfactory nerves, but describes their removal of axon debris, not microbes. The paper mentions trigeminal Schwann cells as possible contaminants of OEC preparations; it does not establish that they phagocytose microbes or that these glia eliminate most microbes reaching the nerves. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [31] Vincent, A. J., Choi-Lundberg, D. L., Harris, J. A., West, A. K. & Chuah, M. I. Bacteria and PAMPs activate nuclear factor kappaB and Gro production in a subset of olfactory ensheathing cells and astrocytes but not in Schwann cells. Glia 55, 905–916. https://doi.org/10.1002/glia.20512 (2007). source
- Premisecitation
Methimazole at 3 days after treatment has been largely cleared.
“as methimazole at this stage has been largely cleared49.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [49] Xie, F. et al. The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5. Drug Metab. Dispos. Boil. Fate Chem. 39, 947–951. https://doi.org/10.1124/dmd.110.037895 (2011). source
- Findingcitation
Long-term infection induced expressions of Ezr and Cldn5.
“Interestingly, long term infection also induced expressions of Ezr91 and Cldn592 which are associated with maintenance of actin cytoskeletal structure, synapse and tight junctions, respectively.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [91] Lanke, V., Moolamalla, S., Roy, D. & Vinod, P. Integrative analysis of hippocampus gene expression profiles identifies network alterations in aging and Alzheimer’s disease. Front. Aging Neurosci. 10, 153 (2018). source
The Results list EZR as a hub gene in an aging- and Alzheimer’s disease-related module, and the Discussion identifies a role for it in the immune synapse; neither passage concerns long-term infection. Searches for infection-induced EZR expression and for CLDN5 found no passage addressing the claimed induction of either gene. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [92] Yamazaki, Y. et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression. Brain 142, 1077–1092 (2019). source
- Findingcitation
Long-term infection depressed the 26S proteasome ubiquitination system by downregulation of Psmd8 and Psmc6.
“The long term infection also depressed the 26S proteasome ubiquitination system by downregulation of Psmd883 and Psmc684 leading to persistence of stress-induced protein aggregates.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [83] Liu, H., Luo, K. & Luo, D. Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease. Sci. Rep. 8, 1–10 (2018). source
The Results section on age-independent differentially expressed genes identifies PSMD8 as a 26S proteasome subunit, but does not report that infection downregulates it. Searches for long-term infection, PSMC6, and proteasome suppression found no passage addressing the claimed effect or its link to persistent protein aggregates. No page number is available in our copy. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [84] Brooks, L. R. & Mias, G. I. Data-driven analysis of age, sex, and tissue effects on gene expression variability in Alzheimer’s disease. Front. Neurosci. 13, 392 (2019). source
The Discussion (§4.1; page not supplied) reports that PSMC6 is downregulated in Alzheimer’s disease and is part of the proteasome complex. It does not establish that long-term infection downregulates PSMC6 or depresses the 26S proteasome system; the cited passage does not report PSMD8 downregulation. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingown data
C. pneumoniae can infect the olfactory and trigeminal nerves, olfactory bulb and brain within 72 h in mice.
“By isolating live C. pneumoniae from tissues and using immunohistochemistry, we show that C. pneumoniae can infect the olfactory and trigeminal nerves, olfactory bulb and brain within 72 h in mice.”
- Also stated in: § Chlamydia pneumoniae infects the olfactory mucosa, olfactory bulb and cerebral cortex within 3 days after intranasal inoculation · plain
“Chlamydia pneumoniae infects the olfactory mucosa, olfactory bulb and cerebral cortex within 3 days after intranasal inoculation”
- Also stated in: § Chlamydia pneumoniae infects the olfactory mucosa, olfactory bulb and cerebral cortex within 3 days after intranasal inoculation · plain
“At 3 and 7 day time-points, infectious C. pneumoniae were isolated from all four tissues (Fig. 2A).”
Quote in the paperSubstantial claim - Also stated in: § Chlamydia pneumoniae infects the olfactory mucosa, olfactory bulb and cerebral cortex within 3 days after intranasal inoculation · plain
- Findingown data
Amyloid beta accumulations were detected adjacent to the C. pneumoniae inclusions in the olfactory system.
“Interestingly, amyloid beta accumulations were also detected adjacent to the C. pneumoniae inclusions in the olfactory system.”
Quote in the paperSubstantial claim - Findingown data
For the olfactory bulb, the number of IFUs was significantly higher at 3 days than 7 days post inoculation.
“For the olfactory bulb, the number of IFUs was significantly higher at 3 days than 7 days post inoculation (p.i.) (Fig. 2A,B), whereas the reverse occurred for the trigeminal nerve (Fig. 2A,B non-injury).”
Quote in the paperNot a substantial claim - Findingown data
Injury to the nasal epithelium resulted in increased peripheral nerve and olfactory bulb infection.
“Furthermore, injury to the nasal epithelium resulted in increased peripheral nerve and olfactory bulb infection, but did not alter general CNS infection.”
Quote in the paperNot a substantial claim - Findingown data
At 28 days, low levels of infectious C. pneumoniae were isolated only from trigeminal nerve post inoculation.
“At 28 days, low levels of infectious C. pneumoniae were isolated only from trigeminal nerve p.i. (not shown).”
Quote in the paperSubstantial claim - Findingown data
At 3 and 7 day time-points, infectious C. pneumoniae were isolated from all four tissues: olfactory mucosa, olfactory bulb, trigeminal nerve and brain.
“At 3 and 7 day time-points, infectious C. pneumoniae were isolated from all four tissues (Fig. 2A).”
Quote in the paperSubstantial claim - Findingown data
No C. pneumoniae were detected in tissue lysate from control (vehicle-inoculated) mice.
“No C. pneumoniae were detected in tissue lysate from control (vehicle-inoculated) mice (n = 2).”
Quote in the paperSubstantial claim - Findingown data
Injury to the nasal epithelium did not alter general CNS infection.
“Furthermore, injury to the nasal epithelium resulted in increased peripheral nerve and olfactory bulb infection, but did not alter general CNS infection.”
Quote in the paperNot a substantial claim - Findingown data
For the trigeminal nerve, the number of IFUs was significantly higher at 7 days than 3 days post inoculation.
“For the olfactory bulb, the number of IFUs was significantly higher at 3 days than 7 days post inoculation (p.i.) (Fig. 2A,B), whereas the reverse occurred for the trigeminal nerve (Fig. 2A,B non-injury).”
Quote in the paperNot a substantial claim - Findingown data
All blood samples showed an absence of C. pneumoniae at 2, 3 and 4 days post intranasal inoculation.
“Based on the curves, all samples showed an absence of C. pneumoniae in blood (Fig. 2C).”
Quote in the paperNot a substantial claim - Findingown data
In vitro, C. pneumoniae was able to infect peripheral nerve and CNS glia.
“In vitro, C. pneumoniae was able to infect peripheral nerve and CNS glia.”
Quote in the paperNot a substantial claim - Findingown data
C. pneumoniae infection resulted in dysregulation of key pathways involved in Alzheimer's disease pathogenesis at 7 and 28 days after inoculation.
“C. pneumoniae infection also resulted in dysregulation of key pathways involved in Alzheimer’s disease pathogenesis at 7 and 28 days after inoculation.”
Quote in the paperSubstantial claim - Findingown data
Molecular pathways related to cell death such as autophagy and apoptosis were up-regulated in cortical tissues at 28 days post inoculation.
“We have also observed similar trends in our study where molecular pathways related to cell death like autophagy and apoptosis were up-regulated in cortical tissues at 28 days post inoculation.”
Quote in the paperSubstantial claim - Findingown data
Epithelial injury resulted in increased C. pneumoniae load in the olfactory bulb compared to mice without injury.
“Epithelial injury resulted in an increased C. pneumoniae load in the olfactory mucosa (which includes the olfactory nerve; both at day 3 and day 7 post inoculation), olfactory bulb and trigeminal nerve (day 7 only) in comparison to mice without injury (Fig. 2A,B).”
Quote in the paperSubstantial claim - Findingown data
In mice not pre-injured, olfactory bulb infection decreased from day 3 to day 7 post inoculation.
“In the pre-injured group, olfactory bulb infection also increased with time, whereas the opposite occurred in mice that were not pre-injured (Fig. 2A,B).”
Quote in the paperNot a substantial claim - Findingown data
Pathologic features of Alzheimer's disease such as activated microglia, production of inflammatory mediators and reactive oxygen species were highly regulated in infected brain tissue at 28 days post inoculation compared with 7 days post inoculation.
“The pathologic features of Alzheimer’s disease like activated microglia, production of inflammatory mediators and reactive oxygen species (ROS) were highly regulated in infected brain tissue at 28 days post inoculation as compared to 7 days post inoculation.”
Quote in the paperSubstantial claim - Findingown data
C. pneumoniae was detected in the glomerular layer of the olfactory bulb at 28 days post inoculation.
“C. pneumoniae was also detected in the glomerular layer of the olfactory bulb at 28 days (Fig. 5Q).”
Quote in the paperSubstantial claim - Findingown data
In one mouse in the pre-injured group, C. pneumoniae inclusions were found in the olfactory piriform cortex.
“In one mouse, in the pre-injured group, C. pneumoniae IB/s were also found in the olfactory piriform cortex, with three-dimensional reconstruction again showing the bacterial DNA being distinct from the host cell DNA (Fig. 4I–K).”
Quote in the paperNot a substantial claim - Findingown data
Chlamydia pneumoniae infection resulted in up-regulation of key pathways involved in Alzheimer's disease pathogenesis.
“Chlamydia pneumoniae infection also resulted in up-regulation of key pathways involved in Alzheimer’s disease pathogenesis.”
Quote in the paperSubstantial claim - Findingown data
Long-term C. pneumoniae infection at day 28 triggered down-regulation of most other key genes involved in Alzheimer's disease pathogenesis.
“Long term C. pneumoniae infection (day 28) triggered down-regulation of most other key genes involved in AD pathogenesis.”
Quote in the paperSubstantial claim - Findingown data
Methimazole treatment clearly damaged the epithelial layer.
“The methimazole treatment clearly damaged the epithelial layer (Fig. 4A–C)”
Quote in the paperSubstantial claim - Findingown data
At 3 and 7 days post intranasal inoculation, C. pneumoniae inclusions were detected in the olfactory nerve, glomerular layer of the olfactory bulb, and trigeminal nerve.
“At later time-points which are sufficient for at least one life cycle, C. pneumoniae inclusions were detected in the olfactory nerve (Fig. 3A–C), glomerular layer of olfactory bulb (Fig. 3D–F) and trigeminal nerve (Fig. 3H–L) at both 3 and 7 days p.i.”
Quote in the paperSubstantial claim - Findingown data
Significantly lower amounts of viable C. pneumoniae were recovered from all the glia than from HEp-2 cells.
“The different glia had similar levels of viable C. pneumoniae, but significantly lower amounts of viable C. pneumoniae were recovered from all the glia than from HEp-2 cells (Fig. 6K).”
Quote in the paperNot a substantial claim - Findingown data
At 3 and 7 days after inoculation, Aβ deposits were detected near C. pneumoniae inclusions in the olfactory nerve.
“At 3 and 7 days after inoculation, we detected Aβ deposits near C. pneumoniae inclusions in the olfactory nerve (Fig. 5C,D,G,H).”
Quote in the paperSubstantial claim - Findingown data
For both pre-injured and non-pre-injured mice, the bacterial load in the trigeminal nerve was higher on day 7 than day 3 post inoculation.
“For both the pre-injured mouse group and the group that was not pre-injured, the bacterial load in the trigeminal nerve was higher on day 7 than day 3 post inoculation (Fig. 2A,B).”
Quote in the paperNot a substantial claim - Findingown data
C. pneumoniae inclusions in the olfactory nerve and bulb were associated with accumulations of Aβ.
“C. pneumoniae inclusions in the olfactory nerve and bulb were associated with accumulations of Aβ”
Quote in the paperSubstantial claim - Findingown data
Epithelial injury resulted in increased C. pneumoniae load in the olfactory mucosa at both day 3 and day 7 post inoculation compared to mice without injury.
“Epithelial injury resulted in an increased C. pneumoniae load in the olfactory mucosa (which includes the olfactory nerve; both at day 3 and day 7 post inoculation), olfactory bulb and trigeminal nerve (day 7 only) in comparison to mice without injury (Fig. 2A,B).”
Quote in the paperSubstantial claim - Findingown data
At 7 days after inoculation, Aβ deposits near C. pneumoniae inclusions were detected in the glomerular layer of the olfactory bulb.
“At 7 days, Aβ deposits near C. pneumoniae inclusions were detected in the glomerular layer of the olfactory bulb (Fig. 5K–N).”
Quote in the paperSubstantial claim - Findingown data
Aβ deposits were not detected in adjacent tissue regions where C. pneumoniae inclusions were not present.
“The Aβ deposits were not detected in adjacent tissue regions where inclusions were not present (Fig. 5O).”
Quote in the paperSubstantial claim - Findingown data
PCA showed maximum variance of 43.03% (PC1) between day 7 and day 28 infected samples.
“The maximum variance across the expressions was 43.03% (PC1 value) between the day 7 and day 28 infected samples (Fig. 7C).”
Quote in the paperNot a substantial claim - Findingown data
At 28 days after inoculation, Aβ deposits continued to be detected near C. pneumoniae inclusions in the glomerular layer of the olfactory bulb.
“At 28 days, Aβ deposits continued to be detected near C. pneumoniae inclusions in the glomerular layer of the olfactory bulb (Fig. 5Q)”
Quote in the paperSubstantial claim - Findingcitation
Bag2 was downregulated in long-term C. pneumoniae infection.
“In addition, Bag2, a Bcl-2 associated co-chaperone gene which controls Hsp70 functionality was also downregulated leading to further failure of the system to protect cells from oxidative damage82.”
Quote in the paperNot a substantial claim - Findingown data
Epithelial injury resulted in increased C. pneumoniae load in the trigeminal nerve at day 7 only compared to mice without injury.
“Epithelial injury resulted in an increased C. pneumoniae load in the olfactory mucosa (which includes the olfactory nerve; both at day 3 and day 7 post inoculation), olfactory bulb and trigeminal nerve (day 7 only) in comparison to mice without injury (Fig. 2A,B).”
Quote in the paperSubstantial claim - Findingcitation
Long-term C. pneumoniae infection downregulated the key protective heat shock protein Hspa1b (Hsp70-2).
“Most importantly there was downregulation of key protective heat shock protein (Hspa1b or Hsp70-2), associated with increased oxidative stress and initiation of AD pathology81.”
Quote in the paperSubstantial claim - Findingown data
Immunolabelling showed C. pneumoniae inclusions in all cell types tested (OECs, TgSCs, astrocytes, microglia, and HEp-2 cells).
“Immunolabelling showed C. pneumoniae inclusions in all cell types (Fig. 6A–J).”
Quote in the paperSubstantial claim - Findingown data
The glial cells populating the olfactory/trigeminal nerves and brain supported C. pneumoniae replication.
“the glial cells populating the olfactory/trigeminal nerves and brain supported C. pneumoniae replication”
Quote in the paperSubstantial claim - Findingown data
Aβ deposits were observed in the olfactory nerve earlier than in the bulb.
“It is interesting that we observed Aβ deposits in the olfactory nerve earlier than in the bulb”
Quote in the paperNot a substantial claim - Findingown data
The UPR pathway was up-regulated in infected cortical tissues at 28 days post inoculation compared with 7 days post inoculation.
“Interestingly, we found UPR pathway being up-regulated in infected cortical tissues at 28 days post inoculation as compared to 7 days post inoculation.”
Quote in the paperSubstantial claim - Findingown data
No evidence of distinct Aβ deposits was detected in brain areas beyond the olfactory bulb.
“Correlating with the fact that we could not detect C. pneumoniae inclusions in the brain beyond the olfactory bulb, we also did not detect any evidence of distinct Aβ deposits in these areas (not shown).”
Quote in the paperSubstantial claim - Findingown data
Epithelial injury did not result in a significant difference in C. pneumoniae load in the brain.
“However, epithelial injury did not result in a significant difference in C. pneumoniae load in the brain.”
Quote in the paperNot a substantial claim - Findingown data
Diffuse/patchy Aβ immunolabelling was present in olfactory nerve and bulb tissues from all animals, including control mice.
“We found diffuse/patchy Aβ immunolabelling in olfactory nerve and bulb tissues from all animals, including control mice (Fig. 5A,B,E,F,I,J,P).”
Quote in the paperNot a substantial claim - Findingown data
In the pre-injured group, olfactory bulb infection increased from day 3 to day 7 post inoculation.
“In the pre-injured group, olfactory bulb infection also increased with time, whereas the opposite occurred in mice that were not pre-injured (Fig. 2A,B).”
Quote in the paperNot a substantial claim - Findingown data
In tissues from inoculated mice, distinct Aβ deposits accumulated near C. pneumoniae inclusions.
“However, we found that in tissues from inoculated mice, distinct Aβ deposits accumulated near C. pneumoniae inclusions.”
Quote in the paperSubstantial claim - Findingown data
C. pneumoniae can infect and replicate to form inclusion bodies within primary glial cells of the olfactory/trigeminal nerves and CNS.
“At the cellular level, we showed that C. pneumoniae can infect and replicate to form inclusion bodies within primary glial cells of the olfactory/trigeminal nerves and CNS.”
Quote in the paperSubstantial claim - Findingown data
C. pneumoniae rapidly invaded the olfactory and trigeminal nerves, the olfactory bulb and brain beyond the bulb in mice.
“We have demonstrated the rapid invasion of the olfactory and trigeminal nerves, the olfactory bulb and brain (beyond the bulb) by C. pneumoniae in mice.”
Quote in the paperSubstantial claim - Findingown data
C. pneumoniae infection led to the dysregulation of key pathways involved in Alzheimer's disease pathogenesis up to 28 days after intranasal inoculation.
“Of particular importance, C. pneumoniae infection led to the dysregulation of key pathways involved in Alzheimer’s disease pathogenesis up to 28 days after intranasal inoculation.”
Quote in the paperSubstantial claim - Findingown data
Long-term infection was associated with low expression of Cd2ap.
“In fact, the long-term infection was also associated with low expression of Cd2ap which has been previously associated with AD pathology aggravated by increased deposition of Aβ and Tau-induced neurotoxicity87.”
Quote in the paperNot a substantial claim - Findingown data
Long-term infection led to higher expression of Cdk18.
“It led to higher expression of Cdk18 which is a cyclin-dependent kinase and usually functions to clear DNA damages88.”
Quote in the paperNot a substantial claim - Findingown data
Upregulation of Flt1 was a key feature in long-term infection.
“In contrast, upregulation of Flt1, a key gene in vascular endothelial growth factor (VEGF) regulation was a key feature in long term infection which could reflect cognition impairment due to higher Aβ and Tau deposition in AD etiopathogenesis, as observed in a previous study95.”
Quote in the paperNot a substantial claim - Findingown data
Hspa4 was upregulated in long-term C. pneumoniae infection.
“Amongst the heat shock proteins, we found Hspa4 to be upregulated which ensured that it maintained the disaggregating property of any misfolded proteins, thereby, preventing further damage and inducing tissue integrity89.”
Quote in the paperNot a substantial claim - Findingcitation
Long-term infection induced the Mbp gene.
“Long term infection also induced Mbp gene, which maintained myelination and prevented further neuroinflammation94.”
Quote in the paperNot a substantial claim - Findingreasoning
Increased Axl activity provided further protection in long-term infection.
“Additionally, further protection was provided by increased Axl activity, a phagocytotic gene (autophagy) important in maintaining homeostatic levels of major AD related lipoprotein, ApoE93.”
Quote in the paperNot a substantial claim - Findingreasoning
Mechanisms inducing chromatin modification, transcription and splicing were highly reduced in long-term infected tissues.
“Thus, mechanisms inducing chromatin modification, transcription and splicing were highly reduced in them.”
Quote in the paperNot a substantial claim - Findingcitation
Infection led to mitochondrial dysfunction evident by downregulation of Ndufa5 and Atp5j2.
“At a sub-cellular level, infection led to mitochondrial dysfunction evident by downregulation of Ndufa5 (a structural subunit of complex I)85 and Atp5j286.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [85] Peralta, S. et al. Partial complex I deficiency due to the CNS conditional ablation of Ndufa5 results in a mild chronic encephalopathy but no increase in oxidative damage. Hum. Mol. Genet. 23, 1399–1412 (2014). source
- cites [86] Liang, W. S. et al. Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl. Acad. Sci. 105, 4441–4446 (2008). source
- Premisecitation
90% of post-mortem patient brains from late-onset dementia patients contained C. pneumoniae DNA, compared with only 5% of control age-matched brains.
“In the late 1990s, it was shown that 90% of such post-mortem patient brains contained C. pneumoniae DNA, compared with only 5% of control age-matched brains9,10.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Balin, B. J. et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med. Microbiol. Immunol. 187, 23–42. https://doi.org/10.1007/s004300050071 (1998). source
- cites [10] Schumacher, H. R. Jr. et al. Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients. Arthritis Rheum. 42, 1889–1893. https://doi.org/10.1002/1529-0131(199909)42:9%3c1889::AID-ANR13%3e3.0.CO;2-W (1999). source
Not checked in the free run.
- Interpretationreasoning
C. pneumoniae can form inclusions in glial cells, suggesting it can overcome phagocytic destruction to some extent.
“The fact that C. pneumoniae can form inclusions in these cells suggest that the bacteria, at least to some extent, can overcome phagocytic destruction”
Quote in the paperSubstantial claim - Interpretationreasoning
Aβ secretion occurs in response to C. pneumoniae infection.
“In combination with the findings of the current study, it appears that Aβ secretion occurs in response to the infection.”
Quote in the paperSubstantial claim - Interpretationown data
C. pneumoniae can very rapidly spread from the periphery to the CNS via the nerves extending between the nasal cavity and the brain, without blood infection.
“Thus, C. pneumoniae can very rapidly spread from the periphery to the CNS via the nerves extending between the nasal cavity and the brain, without blood infection.”
Quote in the paperSubstantial claim - Premisecitation
Methimazole causes degeneration of the nasal epithelium in rodents.
“Methimazole causes degeneration of the nasal epithelium in rodents47.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Brittebo, E. B. Metabolism-dependent toxicity of methimazole in the olfactory nasal mucosa. Pharmacol. Toxicol. 76, 76–79. https://doi.org/10.1111/j.1600-0773.1995.tb00107.x (1995). source
- Interpretationreasoning
C. pneumoniae inclusions in brain tissue were too small or sparse to be confirmed by histology when screening tissue sections.
“suggesting that inclusions in brain tissue were too small or sparse to be confirmed by histology when screening tissue sections.”
Quote in the paperNot a substantial claim - Interpretationown data
C. pneumoniae rapidly infected both the olfactory and trigeminal nerves in mice.
“C. pneumoniae rapidly infected both the olfactory and trigeminal nerves in mice”
Quote in the paperSubstantial claim - Premisecitation
If ER stress due to infection is sustained and misfolded protein cannot be refolded or degraded, cells can directly increase Aβ production and associated neuroinflammation.
“However, if the ER stress due to infection is sustained and misfolded protein cannot be refolded or degraded, the cells can also directly increase Aβ production and associated neuroinflammation80.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [80] Wang, M. & Kaufman, R. J. Protein misfolding in the endoplasmic reticulum as a conduit to human disease. Nature 529, 326–335. https://doi.org/10.1038/nature17041 (2016). source
- Premisecitation
Microglia and astrocytes act as host cells of C. pneumoniae in Alzheimer's disease brain.
“Previous studies have shown that microglia and astrocytes act as host cells of C. pneumoniae in Alzheimer’s disease brain9.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Balin, B. J. et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med. Microbiol. Immunol. 187, 23–42. https://doi.org/10.1007/s004300050071 (1998). source
- Premisecitation
Injuries to the nasal epithelium are relatively common.
“Injuries to the nasal epithelium are, however, relatively common26 and may expose the underlying cranial nerves to infection.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Menick, F. J. & Salibian, A. Primary intranasal lining injury cause, deformities, and treatment plan. Plast. Reconstr. Surg. 134, 1045–1056. https://doi.org/10.1097/PRS.0000000000000694 (2014). source
- Study design and conductown data
C. pneumoniae inclusions and associated Aβ deposits were detected sporadically within tissues, preventing quantification of differences in Aβ levels between time-points and between inoculated and control animals.
“C. pneumoniae inclusions, as well as associated Aβ deposits, were detected sporadically within tissues. For this reason, we were not able to quantify the difference in Aβ levels between tissues from the different time-points after inoculation, as well as between inoculated and control animals.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Overcoming phagocytic destruction may be one important mechanism by which C. pneumoniae can invade and establish long-term infection of the CNS.
“this may be one important mechanism by which this bacterium can invade and establish long-term infection of the CNS.”
Quote in the paperSubstantial claim
- May combine two claims. 36
- Classified as probably not a substantial claim. 32
May combine two claims.
PremisecitationHspa4 maintained the disaggregating property of misfolded proteins, thereby preventing further damage and inducing tissue integrity.
“Amongst the heat shock proteins, we found Hspa4 to be upregulated which ensured that it maintained the disaggregating property of any misfolded proteins, thereby, preventing further damage and inducing tissue integrity89.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [89] Koopman, M. B. & Rüdiger, S. G. Alzheimer cells on their way to derailment show selective changes in protein quality control network. Front. Mol. Biosci. 7, 25 (2020). source
The Results section, “HSP70 Efflux Derails Toward Autophagy” (page unavailable), identifies HSPA4 as contributing to Hsp70-mediated disaggregation but explicitly says its levels remained unaffected in Alzheimer’s brains—not upregulated. It does not report that HSPA4 prevented further damage or improved tissue integrity. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationC. pneumoniae DNA, antigen and/or live bacteria have been detected in the brain of inoculated mice, which resulted in Aβ deposition or altered appearance of Aβ deposits.
“C. pneumoniae DNA, antigen and/or live bacteria have been detected in the brain of inoculated mice15–18, which resulted in Aβ deposition16,17 or altered appearance of Aβ deposits18.”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [15] Little, C. S. et al. Age alterations in extent and severity of experimental in infection with Chlamydophila pneumoniae in BALB/c mice. Infect. Immun. 73, 1723–1734. https://doi.org/10.1128/IAI.73.3.1723-1734.2005 (2005). source
The Results report C. pneumoniae antigen and viable bacteria in the brains of inoculated mice. The Discussion reports Aβ deposits in infected mice from previous work, but this study did not assess Aβ deposition and our copy does not report an altered appearance of Aβ deposits. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [16] Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces alzheimer’s-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25, 419–429. https://doi.org/10.1016/S0197-4580(03)00127-1 (2004). source
- cites [17] Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). source
- cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
The Discussion reports C. pneumoniae DNA in the olfactory bulbs of infected mice one week after inoculation. But it reports nearly identical Aβ immunoreactivity in infected, mock-infected, and uninoculated BALB/c mice, suggesting that the deposits did not directly result from infection. The morphological differences described in the Results are between BALB/c and transgenic mice, not between infected and uninfected BALB/c mice. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationC. pneumoniae can infect lung macrophages, which migrate through the mucosal barrier and enter the blood; the bacteria can disseminate to vasculature by surviving intracellularly in blood monocytes, which can then cross the blood-brain barrier (BBB).
“C. pneumoniae can infect lung macrophages, which migrate through the mucosal barrier and enter the blood; the bacteria can disseminate to vasculature by surviving intracellularly in blood monocytes, which can then cross the blood–brain barrier (BBB)19.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [19] Gieffers, J. et al. Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur. Respir. J. 23, 506–510. https://doi.org/10.1183/09031936.04.00093304 (2004). source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther studies have failed to detect higher levels of C. pneumoniae in post-mortem brains from patients with late-onset dementia.
“In contrast, however, other studies have failed to detect higher levels of C. pneumoniae in post-mortem brains from patients with late-onset dementia14, although the analytical methods have varied between studies7.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [14] Ring, R. H. & Lyons, J. M. Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer’s brain. J. Clin. Microbiol. 38, 2591–2594 (2000). source
May combine two claims.
PremisecitationAβ is an antimicrobial peptide, released by neural cells in response to infectious agents.
“It is now well known that Aβ is an antimicrobial peptide, released by neural cells in response to infectious agents12,13, so it is not surprising that the presence of bacteria in the brain can result in Aβ deposition reviewed in8.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [12] Soscia, S. J. et al. The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505. https://doi.org/10.1371/journal.pone.0009505 (2010). source
The Abstract (Methodology/Principal Findings; page unavailable) reports Aβ’s antimicrobial activity, and the Discussion calls it an antimicrobial peptide. But the Discussion presents increased Aβ generation in response to infection as a possibility, not an established finding, and does not show that neural cells release Aβ in response to infectious agents. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [13] Kumar, D. K. et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci. Transl. Med. 8, 340ra372. https://doi.org/10.1126/scitranslmed.aaf1059 (2016). source
The Introduction and Discussion describe Aβ’s antimicrobial activity, and the Results report that cultured human brain neuroglioma cells secrete Aβ. But the Discussion says the study’s models expressed Aβ constitutively and could not test whether infection normally increases its production; it cites other investigators’ findings only as suggesting that Aβ may be inducible. The source therefore does not establish that neural cells release Aβ in response to infectious agents. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationreasoningThe mice used in these studies were wild-type mice and not mouse models of Alzheimer's disease, suggesting that C. pneumoniae can contribute to the neuropathologies associated with late-onset dementia.
“Importantly, the mice used in these studies were wild-type mice and not mouse models of Alzheimer’s disease, suggesting that C. pneumoniae can contribute to the neuropathologies associated with late-onset dementia.”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [15] Little, C. S. et al. Age alterations in extent and severity of experimental in infection with Chlamydophila pneumoniae in BALB/c mice. Infect. Immun. 73, 1723–1734. https://doi.org/10.1128/IAI.73.3.1723-1734.2005 (2005). source
- cites [16] Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces alzheimer’s-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25, 419–429. https://doi.org/10.1016/S0197-4580(03)00127-1 (2004). source
- cites [17] Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). source
- cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
The Discussion identifies the infected BALB/c mice as naïve, non-transgenic mice, supporting the wild-type part of the claim. But it reports similar Aβ immunoreactivity in infected and uninfected mice and concludes that the data do not unequivocally support infection-induced AD-like plaques. The proposed contribution to late-onset dementia remains a possibility, not a finding established by this study. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationChlamydia infection can induce cellular stress that impacts protein folding, thus inducing UPR activation; it is also proposed to modulate the UPR to promote its survival and replication.
“Chlamydia infection can induce cellular stress that impacts protein folding, thus inducing UPR activation however it is also proposed to modulate the UPR to promote their survival and replication79.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [79] Smith, J. A. Regulation of cytokine production by the unfolded protein response; implications for infection and autoimmunity. Front. Immunol. https://doi.org/10.3389/fimmu.2018.00422 (2018). source
The 'Implications for Bacterial Infections' section (page not provided) reports that Chlamydia infection activates several ER-stress pathways, supporting the first part of the claim. It does not propose that Chlamydia modulates the UPR to promote its own survival or replication; the discussion of UPR-supported bacterial replication concerns Brucella. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAfter approximately 72 h (in cell culture), the RBs transform into EBs, which are released by cell lysis and can infect new cells.
“After approximately 72 h (in cell culture), the RBs transform into EBs, which are released by cell lysis and can infect new cells (exit via extrusion of membrane-bound compartments can also occur39).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [36] Abdelrahman, Y. M. & Belland, R. J. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29, 949–959. https://doi.org/10.1016/j.femsre.2005.03.002 (2005). source
- cites [39] Zuck, M., Sherrid, A., Suchland, R., Ellis, T. & Hybiske, K. Conservation of extrusion as an exit mechanism for Chlamydia. Pathog. Dis. https://doi.org/10.1093/femspd/ftw093 (2016). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSeveral reports have described manifestations of ER stress in post-mortem brain samples from Alzheimer's disease patients.
“Several reports have described manifestations of ER stress in post-mortem brain samples from Alzheimer’s disease patients78.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [78] Hashimoto, S. & Saido, T. C. Critical review: Involvement of endoplasmic reticulum stress in the aetiology of Alzheimer’s disease. Open Biol. 8, 180024. https://doi.org/10.1098/rsob.180024 (2018). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMicroglia activation reduces the accumulation of Aβ in the brain by increasing its phagocytosis, clearance, and degradation.
“Microglia activation reduces the accumulation of Aβ in the brain by increasing its phagocytosis, clearance, and degradation75.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [75] Ries, M. & Sastre, M. Mechanisms of Aβ clearance and degradation by glial cells. Front. Aging Neurosci. https://doi.org/10.3389/fnagi.2016.00160 (2016). source
The Phagocytosis section says microglia phagocytose Aβ, and the Conclusion says activated glial cells can promote its removal. But the Conclusion associates this protective function with a particular, alternatively activated microglial phenotype and also notes potentially detrimental effects of activation. The claim overstates this as an unqualified effect of microglial activation. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe glia limitans layer between the peripheral nerves and brain, populated by astrocytes, constitutes a further immunological barrier against CNS infection.
“The glia limitans layer between the peripheral nerves and brain, populated by astrocytes, constitutes a further immunological barrier against CNS infection32,33.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [32] Nazareth, L. et al. Novel insights into the glia limitans of the olfactory nervous system. J. Comp. Neurol. 527, 1228–1244. https://doi.org/10.1002/cne.24618 (2019). source
- cites [33] Jung, Y.-J. & Chung, W.-S. Phagocytic roles of glial cells in healthy and diseased brains. Biomol. Ther. (Seoul) 26, 350–357. https://doi.org/10.4062/biomolther.2017.133 (2018). source
The Introduction discusses astrocytes and glial phagocytosis as an innate immune defense, but does not describe the glia limitans or an astrocyte-populated barrier against CNS infection. Searches for the glia limitans and for a barrier between peripheral nerves and the brain found no passage addressing that claim in our copy. (LLM, conf=0.74)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationC. pneumoniae EBs can become internalized into host cells, including many phagocytes.
“C. pneumoniae EBs can become internalized into host cells, including many phagocytes1,37,38.”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [1] Beagley, K. W., Huston, W. M., Hansbro, P. M. & Timms, P. Chlamydial infection of immune cells: Altered function and implications for disease. Crit. Rev. Immunol. 29, 275–305 (2009). source
- cites [37] Armitage, C. W., O’Meara, C. P. & Beagley, K. W. Chlamydia pneumoniae and Chlamydia trachomatis infection differentially modulates human dendritic cell line (MUTZ) differentiation and activation. Scand. J. Immunol. 82, 48–54. https://doi.org/10.1111/sji.12295 (2015). source
The Results section reports internalized C. pneumoniae elementary bodies in iMUTZ dendritic cells, supporting uptake by a host phagocyte. The Introduction describes infection of several immune-cell types by Chlamydia species generally, but does not establish that C. pneumoniae EBs enter many types of phagocytes specifically. Page numbers are unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [38] Herweg, J. A. & Rudel, T. Interaction of Chlamydiae with human macrophages. FEBS J. 283, 608–618. https://doi.org/10.1111/febs.13609 (2016). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExperimental injury to the olfactory neuroepithelium facilitates invasion of the olfactory nerve and bulb by certain bacteria.
“It has previously been shown that experimental injury to the olfactory neuroepithelium facilitates invasion of the olfactory nerve and bulb by certain bacteria27,28.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [27] Walkden, H. et al. Burkholderia pseudomallei invades the olfactory nerve and bulb after epithelial injury in mice and causes the formation of multinucleated giant glial cells in vitro. PLoS Negl. Trop. Dis. 14, e0008017. https://doi.org/10.1371/journal.pntd.0008017 (2020). source
- cites [28] Herbert, R. P. et al. Cytokines and olfactory bulb microglia in response to bacterial challenge in the compromised primary olfactory pathway. J. Neuroinflamm. 9, 109. https://doi.org/10.1186/1742-2094-9-109 (2012). source
Classified as probably not a substantial claim.
PremisecitationIn a transgenic mouse model of familial Alzheimer's disease (5xFAD mice), intracranial injection with Salmonella typhimurium resulted in a dramatic increase in Aβ deposition after only 48 h.
“In a transgenic mouse model of familial Alzheimer’s disease (5xFAD mice, which exhibit the human amyloid precursor protein and presenilin 1 transgenes with five mutations linked to Alzheimer’s disease), intracranial injection with Salmonella typhimurium resulted in a dramatic increase in Aβ deposition after only 48 h13.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [13] Kumar, D. K. et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci. Transl. Med. 8, 340ra372. https://doi.org/10.1126/scitranslmed.aaf1059 (2016). source
Classified as probably not a substantial claim.
PremisecitationThe capacity to infect and survive inside glial cells is thought to be a key mechanism for the ability of bacteria to invade the CNS via cranial nerves.
“The capacity to infect and survive inside glial cells is thought to be a key mechanism for the ability of bacteria to invade the CNS via cranial nerves34,35.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [34] Macedo-Ramos, H. et al. Olfactory ensheathing cells as putative host cells for Streptococcus pneumoniae: Evidence of bacterial invasion via mannose receptor-mediated endocytosis. Neurosci. Res. 69, 308–313. https://doi.org/10.1016/j.neures.2010.12.015 (2011). source
The Discussion (page unavailable) proposes that olfactory ensheathing cells harboring Streptococcus pneumoniae could provide a route into the CNS, and the Methods describe recovering colony-forming bacteria from lysed host cells after infection. This supports the proposed mechanism for pneumococci via the olfactory route, but the paper does not establish it as a key mechanism for bacteria generally or for invasion via cranial nerves broadly. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [35] Delbaz, A. et al. Neisseria meningitidis induces pathology-associated cellular and molecular changes in trigeminal schwann cells. Infect. Immun. https://doi.org/10.1128/IAI.00955-19 (2020). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBag2 is a Bcl-2 associated co-chaperone gene that controls Hsp70 functionality.
“In addition, Bag2, a Bcl-2 associated co-chaperone gene which controls Hsp70 functionality was also downregulated leading to further failure of the system to protect cells from oxidative damage82.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Qin, L., Guo, J., Zheng, Q. & Zhang, H. BAG2 structure, function and involvement in disease. Cell. Mol. Biol. Lett. 21, 1–11 (2016). source
May combine two claims.
InterpretationcitationAβ may be secreted as a normal immune response to any microbe that invades the nervous system, and if infection clears, deposited Aβ can be cleared by phagocytic glia.
“The secretion of Aβ may thus be a normal immune response to any microbe that may invade the nervous system, and if infection clears, the deposited Aβ can be cleared by phagocytic glia71.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [71] Ries, M. & Sastre, M. Mechanisms of abeta clearance and degradation by glial cells. Front. Aging Neurosci. 8, 160. https://doi.org/10.3389/fnagi.2016.00160 (2016). source
The Aβ Internalisation > Phagocytosis section (page not provided) says microglia phagocytose fibrillar Aβ, supporting clearance by phagocytic glia. The paper does not say that Aβ secretion is an immune response to invading microbes or that its deposits are cleared specifically after an infection resolves. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationChlamydia muridarum can quickly (within two days) enter the CNS via the olfactory and/or trigeminal nerves.
“We recently demonstrated that Chlamydia muridarum can quickly (within two days) enter the CNS via these paths24, suggesting that C. pneumoniae may also rapidly infect the brain via the nerves.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [24] Nazareth, L. et al. Chlamydia muridarum can invade the central nervous system via the olfactory and trigeminal nerves and infect peripheral nerve glial cells. Front Cell Infect. Microbiol. 10, 607779. https://doi.org/10.3389/fcimb.2020.607779 (2020). source
May combine two claims.
PremisecitationNeuroinflammatory responses are considered a major driving factor in patients with neurodegeneration and Alzheimer's disease pathology, which starts early in the course of the disease, prior to the formation of Aβ plaques in the brain.
“Theses neuroinflammatory responses are considered a major driving factor in patients with neurodegeneration and Alzheimer’s disease pathology, which starts early in the course of the disease, prior to the formation of Aβ plaques in the brain73.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [73] Kinney, J. W. et al. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y) 4, 575–590. https://doi.org/10.1016/j.trci.2018.06.014 (2018). source
The Overview and Inflammation in AD sections describe sustained neuroinflammation as a central feature of neurodegenerative disorders and a contributor to AD pathology. They do not establish that it begins before Aβ plaques form; the Microglia section instead describes Aβ as a hypothesized primary driver of microglial activation. The paper copy provides no page numbers for these passages. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationChlamydiae can also persistently infect cells which is likely relevant for the link to chronic diseases.
“Chlamydiae can also persistently infect cells40 which is likely relevant for the link to chronic diseases1.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [40] Airenne, S. et al. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 67, 1445–1449 (1999). source
- cites [1] Beagley, K. W., Huston, W. M., Hansbro, P. M. & Timms, P. Chlamydial infection of immune cells: Altered function and implications for disease. Crit. Rev. Immunol. 29, 275–305 (2009). source
Classified as probably not a substantial claim.
PremisecitationCertain other bacteria have been shown to very rapidly (within days) reach the CNS via the olfactory and/or trigeminal nerves.
“Certain other bacteria, however, have been shown to very rapidly (within days) reach the CNS via the olfactory and/or trigeminal nerves reviewed in20.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [20] Dando, S. J. et al. Pathogens penetrating the central nervous system: Infection pathways and the cellular and molecular mechanisms of invasion. Clin. Microbiol. Rev. 27, 691–726. https://doi.org/10.1128/CMR.00118-13 (2014). source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationreasoningThe faster time-frame may be due to differences in inoculation dose since they used a higher dose than two previous studies but lower than another.
“which may be due to differences in the inoculation dose since we used a higher inoculation dose than two previous studies16,50 but lower than another18.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [16] Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J. & Appelt, D. M. Chlamydia pneumoniae induces alzheimer’s-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging 25, 419–429. https://doi.org/10.1016/S0197-4580(03)00127-1 (2004). source
- cites [50] Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). source
- cites [18] van Boelen, E. et al. Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection. Acta Neuropathol. 114, 255–261. https://doi.org/10.1007/s00401-007-0252-3 (2007). source
May combine two claims.
PremisecitationFollowing infection, activated microglia and astrocytes secrete pro-inflammatory cytokines, including IL-1β, TNFα and IL-6, which are neurotoxic and may directly increase Aβ production via activation of β-secretase (BACE).
“It has been shown that following infection, activated microglia and astrocytes secrete pro-inflammatory cytokines, including IL-1β, TNFα and IL-6 which are neurotoxic and may directly increase Aβ production via activation of β-secretase (BACE)66,74.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [66] Al-Atrache, Z., Lopez, D. B., Hingley, S. T. & Appelt, D. M. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease. BMC Neurosci. 20, 6–6. https://doi.org/10.1186/s12868-019-0489-5 (2019). source
The Background (page unavailable) links infectious stimuli to inflammatory cytokine release and altered BACE1 activity, and the Results report increased BACE1 activity after infection of astrocytoma cells. The paper does not show that infected microglia and astrocytes secrete the specified IL-1β, TNFα, and IL-6, or that those cytokines directly cause the increase in Aβ through BACE1. Its Discussion reports increased transcription of IL-1α, not IL-1β, in infected astrocytes. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [74] Alasmari, F., Alshammari, M. A., Alasmari, A. F., Alanazi, W. A. & Alhazzani, K. Neuroinflammatory cytokines induce amyloid beta neurotoxicity through modulating amyloid precursor protein levels/metabolism. Biomed. Res. Int. 3087475–3087475, 2018. https://doi.org/10.1155/2018/3087475 (2018). source
Section 2.2 reports that TNF-α and IFN-γ enhance β-secretase expression in an AD mouse model, with increased Aβ deposition. The Introduction also says inflammatory cytokines can cause neurodegeneration. Our copy does not establish the claimed sequence following infection or show that activated microglia and astrocytes secrete all three listed cytokines, including IL-6, to increase Aβ through β-secretase. Page numbers were not available in the indexed passages. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationUpregulation of Flt1 could reflect cognition impairment due to higher Aβ and Tau deposition in Alzheimer's disease etiopathogenesis.
“In contrast, upregulation of Flt1, a key gene in vascular endothelial growth factor (VEGF) regulation was a key feature in long term infection which could reflect cognition impairment due to higher Aβ and Tau deposition in AD etiopathogenesis, as observed in a previous study95.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [95] Mahoney, E. R. et al. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease. Mol. Psychiatry 26, 888–896 (2021). source
The Results (Associations with cognition and Associations with pathology; page unavailable) link higher FLT1 expression to worse cognitive trajectories and greater β-amyloid burden, but do not find a significant gene-level association with tau burden. The Discussion reports associations for some membrane-bound FLT1 isoforms with tau and says it is unclear whether expression changes are a cause or consequence of neuropathology. The proposed explanation involving both deposits therefore goes beyond what the study establishes. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCd2ap has been previously associated with Alzheimer's disease pathology aggravated by increased deposition of Aβ and Tau-induced neurotoxicity.
“In fact, the long-term infection was also associated with low expression of Cd2ap which has been previously associated with AD pathology aggravated by increased deposition of Aβ and Tau-induced neurotoxicity87.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [87] Tao, Q.-Q., Chen, Y.-C. & Wu, Z.-Y. The role of CD2AP in the pathogenesis of Alzheimer’s disease. Aging Dis. 10, 901 (2019). source
The Conclusions (page unavailable) link CD2AP loss of function to altered Aβ metabolism and Tau-induced neurotoxicity. The amyloidogenesis section discusses Aβ generation and levels, but does not establish that CD2AP loss increases Aβ deposition specifically. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMbp maintained myelination and prevented further neuroinflammation.
“Long term infection also induced Mbp gene, which maintained myelination and prevented further neuroinflammation94.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [94] Ou-Yang, M.-H. & Van Nostrand, W. E. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice. J. Neuroinflamm. 10, 1–12 (2013). source
The Background identifies MBP as a major structural protein of the myelin sheath, and the Discussion links MBP loss and abnormal myelination to increased neuroinflammatory cells. The paper studies MBP-deficient mice; it does not show that infection-induced Mbp maintained myelination or prevented further inflammation during infection. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCdk18 is a cyclin-dependent kinase that usually functions to clear DNA damages.
“It led to higher expression of Cdk18 which is a cyclin-dependent kinase and usually functions to clear DNA damages88.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [88] Barone, G. et al. Human CDK18 promotes replication stress signaling and genome stability. Nucleic Acids Res. 44, 8772–8785 (2016). source
The Introduction identifies CDK18 as a cyclin-dependent kinase. The Results report that CDK18-depleted cells accumulate DNA damage and cannot efficiently repair DNA breaks by homologous recombination. This supports a role in the DNA-damage response, but the paper characterizes CDK18 chiefly as a regulator of replication-stress signaling, not as a kinase that usually clears DNA damage. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAxl is a phagocytotic gene important in maintaining homeostatic levels of the major Alzheimer's disease related lipoprotein ApoE.
“Additionally, further protection was provided by increased Axl activity, a phagocytotic gene (autophagy) important in maintaining homeostatic levels of major AD related lipoprotein, ApoE93.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [93] Zhao, W. et al. Axl receptor tyrosine kinase is a regulator of apolipoprotein E. Mol. Brain 13, 1–13 (2020). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSumf2 is associated with modulation of tissue homeostasis.
“Additionally, it also helped in sulfatase gene (Sumf2) maintenance which is associated with modulation of tissue homeostasis90.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [90] Roberts, R. O. et al. Decreased expression of sulfatase 2 in the brains of Alzheimer’s disease patients: Implications for regulation of neuronal cell signaling. J. Alzheimer’s Dis. Rep. 1, 115–124 (2017). source
The Introduction says SULF2 modulates homeostasis, but the claim names Sumf2. Searches for “SUMF2” and “Sumf2 maintenance” returned passages about SULF2, not Sumf2; our copy does not establish the claimed association for Sumf2. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEzr and Cldn5 are associated with maintenance of actin cytoskeletal structure, synapse and tight junctions, respectively.
“Interestingly, long term infection also induced expressions of Ezr91 and Cldn592 which are associated with maintenance of actin cytoskeletal structure, synapse and tight junctions, respectively.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [91] Lanke, V., Moolamalla, S., Roy, D. & Vinod, P. Integrative analysis of hippocampus gene expression profiles identifies network alterations in aging and Alzheimer’s disease. Front. Aging Neurosci. 10, 153 (2018). source
- cites [92] Yamazaki, Y. et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression. Brain 142, 1077–1092 (2019). source
May combine two claims.
Findingown dataC. pneumoniae could infect, survive in and replicate within glia from the PNS (OECs and TgSCs) and the CNS (astrocytes and microglia).
“We here showed that C. pneumoniae could infect, survive in and replicate (form inclusions) within glia from the PNS (OECs and TgSCs) and the CNS (astrocytes and microglia).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn C. pneumoniae-infected mouse brains, 514 genes were up-regulated at day 7 and 232 genes at day 28 compared to non-infected controls, with 81 genes common to both.
“We found that a total of 514 genes were up-regulated in day 7 samples compared to 232 genes in day 28, out of which 81 genes were common to both and 433 (84.2%) were exclusively up-regulated in day 7 while 151 (65.1%) were exclusively up-regulated by day 28 (Fig. 7A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDespite isolating viable C. pneumoniae from the brain beyond the olfactory bulb, no definitive C. pneumoniae inclusions were found in brain tissue sections from these mice.
“Despite being able to isolate viable C. pneumoniae from the brain (beyond the bulb), we did not find definitive C. pneumoniae inclusions in brain tissue sections from these mice (not shown)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataWithin the olfactory bulb, C. pneumoniae was only detected within the nerve fibre layer and glomerular layer, with inclusion bodies present inside OECs.
“Within the olfactory bulb, C. pneumoniae was only detected within the nerve fibre layer and glomerular layer, with C. pneumoniae inclusion bodies being present inside OECs (Fig. 3G).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataC. pneumoniae was detected within the olfactory mucosa and olfactory bulb 24 h after intranasal inoculation, and infectious C. pneumoniae were isolated from both the olfactory mucosa and olfactory bulb.
“24 h after inoculation C. pneumoniae was detected within the olfactory mucosa and olfactory bulb and infectious C. pneumoniae were isolated from both the olfactory mucosa and olfactory bulb (Supplementary Fig. 1).”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningAs a result of increased growth factor signalling, angiogenesis was induced with increased trophic activity demonstrating ongoing inflammatory activity.
“As a result of increased growth factor signalling, angiogenesis was induced with increased trophic activity demonstrating ongoing inflammatory activity.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataInjury to the nasal epithelium led to increased bacterial load in the peripheral nerves and olfactory bulb, but did not increase load in the rest of the brain during the time course of the study.
“We also showed that injury to the nasal epithelium led to increased bacterial load in the peripheral nerves and olfactory bulb, but did not increase load in the rest of the brain during the time course of our study.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the olfactory nerve and bulb, C. pneumoniae inclusions were associated with localized deposits of Aβ, which appeared in the olfactory nerve earlier than in the bulb.
“In the olfactory nerve and bulb, C. pneumoniae inclusions were associated with localized deposits of Aβ, which appeared in the olfactory nerve earlier than in the bulb.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAll these gene modulations led to increased unfolded protein response, oxidative stress, and higher disease association as evident by the biological processes heat map.
“Nevertheless, all these gene modulations led to increased unfolded protein response, oxidative stress, and had higher disease association as evident by the biological processes heat map.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationHspa4 helped in sulfatase gene (Sumf2) maintenance.
“Additionally, it also helped in sulfatase gene (Sumf2) maintenance which is associated with modulation of tissue homeostasis90.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe nerves extending between the nasal cavity and the brain constitute invasion paths by which C. pneumoniae can rapidly invade the CNS likely by surviving in glia and leading to Aβ deposition.
“In summary, the nerves extending between the nasal cavity and the brain constitute invasion paths by which C. pneumoniae can rapidly invade the CNS likely by surviving in glia and leading to Aβ deposition.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings in intranasally inoculated mice about C. pneumoniae CNS invasion and Aβ deposition are relevant to human late-onset Alzheimer's disease.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIntracellular pathogens like Chlamydia would benefit from UPR because increased folding capacity and activation of lipid biosynthesis can sustain bacterial replication.
“Intracellular pathogens like Chlamydia would benefit from UPR since increase in folding capacity and activation of lipid biosynthesis can sustain bacterial replication.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe experimental procedures used in the study were conducted with the approval of the Griffith University Biosafety Committee and the Griffith University Animal Ethics Committee in accordance with guidelines.
“The experimental procedures used in the study were conducted with the approval of the Griffith University Biosafety Committee (NLRD/09/15_var7) and the Griffith University Animal Ethics Committee (MSC/08/18/AEC) in accordance with guidelines of the Australian Commonwealth Office of Gene Technology Regulator and the National Health and Medical Research Council of Australia.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAβ oligomers have also been proposed to cause ER dysfunction leading to UPR-mediated neurotoxicity and neuronal cell death.
“Conversely, Aβ oligomers have also been proposed to cause ER dysfunction leading to UPR mediated neurotoxicity and neuronal cell death77.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Hetz, C. & Mollereau, B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233–249. https://doi.org/10.1038/nrn3689 (2014). source
May combine two claims.
Interpretationown dataC. pneumoniae entered the CNS via nerves within 24-72 h after intranasal inoculation and without concurrent blood infection.
“C. pneumoniae entered the CNS via nerves within 24–72 h after intranasal inoculation and without concurrent blood infection”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataInjury to the nasal epithelium exacerbated peripheral nerve infection, but reduced brain infection.
“injury to the nasal epithelium exacerbated peripheral nerve infection, but reduced brain infection”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll animal experiments in this study are reported in accordance with ARRIVE guidelines.
“All the animal experiments in this study are reported in accordance with ARRIVE guidelines (https://arriveguidelines.org).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFor comparison between groups, the same image capture settings, laser intensity and focal depths were used.
“For comparison between groups, the same image capture settings, laser intensity and focal depths were used.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataC. pneumoniae infection leads to differential regulation of Alzheimer's disease genes, with long-term infection (day 28) down-regulating most genes related to protein folding and aiding in misaggregation.
“In summary, these findings suggest that C. pneumoniae infection leads to a differential regulation of Alzheimer’s disease genes with long term infection (day 28) down-regulating most of the genes related to folding of proteins and aiding in misaggregation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHspa1b (Hsp70-2) is associated with increased oxidative stress and initiation of Alzheimer's disease pathology.
“Most importantly there was downregulation of key protective heat shock protein (Hspa1b or Hsp70-2), associated with increased oxidative stress and initiation of AD pathology81.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Clarimón, J., Bertranpetit, J., Boada, M., Tàrraga, L. & Comas, D. HSP70-2 (HSPA1B) is associated with noncognitive symptoms in late-onset Alzheimer’s disease. J. Geriatr. Psychiatry Neurol. 16, 146–150 (2003). source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationChlamydiae are obligate intracellular bacteria with a unique biphasic life-cycle.
“Chlamydiae are obligate intracellular bacteria with a unique biphasic life-cycle reviewed in36.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Abdelrahman, Y. M. & Belland, R. J. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29, 949–959. https://doi.org/10.1016/j.femsre.2005.03.002 (2005). source
May combine two claims.
Interpretationown dataThe duration of infection had a definite role in differential gene expression of Alzheimer's disease genes, as biological replicates from respective time points clustered together but away from each other as a group.
“This analysis showed that the duration of infection had a definite role as the individual biological replicates from respective time points clustered together but away from each other as a group.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe nerves are well-protected physically and immunologically by the nasal epithelium which exhibits powerful innate and adaptive immune system components; together with NALT, the epithelium constitutes the first defence against microbes.
“The nerves are well-protected physically and immunologically by the nasal epithelium which exhibits powerful innate and adaptive immune system components. Together with the associated nasopharynx-associated lymphoid tissue (NALT), the epithelium constitutes the first defence against microbes25.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Wu, H. Y. & Russell, M. W. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system. Immunol. Res. 16, 187–201 (1997). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn APP/PS1 mice, the terminal end of the olfactory nerve within the nasal olfactory epithelium is the first nervous system area to exhibit Aβ deposition, which then progresses to the olfactory bulb and other CNS areas.
“one study in an Alzheimer’s disease mouse model (APP/PS1 mice) showed that the terminal end of the olfactory nerve within the nasal olfactory epithelium is the first nervous system area to exhibit Aβ deposition, which then progresses to the olfactory bulb and other CNS areas72.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [72] Wu, N., Rao, X., Gao, Y., Wang, J. & Xu, F. Amyloid-beta deposition and olfactory dysfunction in an Alzheimer’s disease model. J. Alzheimer’s Dis. 37, 699–712. https://doi.org/10.3233/JAD-122443 (2013). source
May combine two claims.
PremisecitationPersistent Chlamydia infection can last for many years, and the persistent Chlamydia bacteria can re-activate.
“Persistent Chlamydia infection can last for many years, and the persistent Chlamydia bacteria can re-activate41,42.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [41] Dean, D., Suchland, R. J. & Stamm, W. E. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182, 909–916. https://doi.org/10.1086/315778 (2000). source
- cites [42] Hammerschlag, M. R. et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14, 178–182. https://doi.org/10.1093/clinids/14.1.178 (1992). source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDisturbance of endoplasmic reticulum function is emerging as a relevant factor driving neurodegeneration in Alzheimer's disease.
“Disturbance of endoplasmic reticulum (ER) function is emerging as a relevant factor driving neurodegeneration in Alzheimer’s disease77.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Hetz, C. & Mollereau, B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15, 233–249. https://doi.org/10.1038/nrn3689 (2014). source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRBs replicate in inclusions (modified cellular vacuoles), which expand in size as the bacteria replicate.
“RBs replicate in inclusions (modified cellular vacuoles), which expand in size as the bacteria replicate.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Abdelrahman, Y. M. & Belland, R. J. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29, 949–959. https://doi.org/10.1016/j.femsre.2005.03.002 (2005). source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenPrimary glial cultures with approximately 70-80% purity were used in the experiments.
“Primary glial cultures with approximately 70–80% purity was used in the experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOutside of host cells, Chlamydiae exist as infectious, biologically inactive elementary bodies (EBs), which exhibit strong resistance to environmental stress.
“Outside of host cells, Chlamydiae exist as infectious, biologically inactive elementary bodies (EBs), which exhibit strong resistance to environmental stress.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Abdelrahman, Y. M. & Belland, R. J. The chlamydial developmental cycle. FEMS Microbiol. Rev. 29, 949–959. https://doi.org/10.1016/j.femsre.2005.03.002 (2005). source
May combine two claims.
InterpretationreasoningLong-term infection induced greater organisation of neuronal cytoskeleton and/or dendritic structure while also maintaining synaptic transmission and reuptake.
“This ensured that long-term infection induced greater organisation of neuronal cytoskeleton and/or dendritic structure while also maintaining synaptic transmission and reuptake.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe nerves extending between the nasal cavity and the brain constitute invasion paths by which C. pneumoniae can rapidly invade the CNS and trigger genetic and molecular changes in the longer term which may contribute to the onset of Alzheimer's disease pathogenesis.
“From these results, we conclude that the nerves extending between the nasal cavity and the brain constitute invasion paths by which C. pneumoniae can rapidly invade the CNS and trigger genetic and molecular changes in the longer term which may contribute to the onset of Alzheimer’s disease pathogenesis.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Findings in intranasally inoculated mice about C. pneumoniae CNS invasion and Aβ deposition are relevant to human late-onset Alzheimer's disease.
“In summary, the nerves extending between the nasal cavity and the brain constitute invasion paths by which C. pneumoniae can rapidly invade the CNS likely by surviving in glia and leading to Aβ deposition.”
The paper relies on this without support.
The mouse model of intranasal inoculation recapitulates natural human exposure to C. pneumoniae.
“In the current study, we investigated whether C. pneumoniae could rapidly (3–7 days after intranasal inoculation) invade the CNS via the olfactory and/or trigeminal nerves in mice and if this resulted in any alterations in Aβ deposition in nerve/CNS tissue.”
The paper relies on this without support.
Bacteria detected at 24 h after intranasal inoculation are likely from the inoculum rather than newly replicating.
“as the bacteria at 24 h was likely to be from the inoculum we did not analyse this tissue further.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure 5 assigns the same panels to control and inoculated mice
MinorThe Figure 5 caption labels panels E and F as both control and inoculated olfactory-nerve images at seven days.
“(E,F) control”
“(E,F) inoculated mice.”
Discussion says injury reduced brain infection despite no significant difference
MinorThe discussion describes reduced brain infection after nasal epithelial injury, whereas the results say injury did not produce a significant difference in brain bacterial load.
“injury to the nasal epithelium exacerbated peripheral nerve infection, but reduced brain infection”
“However, epithelial injury did not result in a significant difference in C. pneumoniae load in the brain.”
Cites
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253 · see citing works
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · see citing works
Protein misfolding in the endoplasmic reticulum as a conduit to human disease
Wang, M., & Kaufman, R. J. (2016) · Nature · doi:10.1038/nature17041 · Cited by 1,630 · see citing works
Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00758-5 · Cited by 1,458 · see citing works
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060 · see citing works
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971 · see citing works
Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
Hetz, C., & Mollereau, B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3689 · Cited by 684 · see citing works
The chlamydial developmental cycle: Figure 1
AbdelRahman, Y. M., & Belland, R. J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2005.03.002 · Cited by 631 · see citing works
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585 · see citing works
Microbes and Alzheimer’s Disease
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532 · see citing works
Mechanisms of Aβ Clearance and Degradation by Glial Cells
Ries, M., & Sastre, M. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00160 · Cited by 527 · see citing works
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain
Balin, B. J., Gérard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., & Hudson, A. P. (1998) · Medical Microbiology and Immunology · doi:10.1007/s004300050071 · Cited by 506 · see citing works
Dando, S. J., Mackay-Sim, A., Norton, R., Currie, B. J., St. John, J. A., Ekberg, J. A. K., Batzloff, M., Ulett, G. C., & Beacham, I. R. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00118-13 · Cited by 428 · see citing works
Self-citationOlfactory and other sensory impairments in Alzheimer disease
Murphy, C. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0097-5 · Cited by 425 · see citing works
Drossaers-Bakker, K. W., de Buck, M., van Zeben, D., Zwinderman, A. H., Breedveld, F. C., & Hazes, J. M. W. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9 · Cited by 373 · see citing works
Persistent Infection with Chlamydia pneumoniae following Acute Respiratory Illness
Hammerschlag, M. R., Chirgwin, K., Roblin, P. M., Gelling, M., Dumornay, W., Mandel, L., Smith, P., & Schachter, J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.178 · Cited by 315 · see citing works
Phagocytosis in the Brain: Homeostasis and Disease
Galloway, D. A., Phillips, A. E. M., Owen, D. R., & Moore, C. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00790 · Cited by 304 · see citing works
Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice
Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J., & Appelt, D. M. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00127-1 · Cited by 243 · see citing works
Does Alzheimer's disease begin in the brainstem?
Simic, G., Stanic, G., Mladinov, M., Jovanov‐Milosevic, N., Kostovic, I., & Hof, P. R. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01038.x · Cited by 204 · see citing works
Yamazaki, Y., Shinohara, M., Shinohara, M., Yamazaki, A., Murray, M. E., Liesinger, A. M., Heckman, M. G., Lesser, E. R., Parisi, J. E., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz011 · Cited by 202 · see citing works
Evidence for Long‐Term Cervical Persistence of<i>Chlamydia trachomatis</i>by<i>omp1</i>Genotyping
Dean, D., Suchland, R. J., & Stamm, W. E. (2000) · The Journal of Infectious Diseases · doi:10.1086/315778 · Cited by 193 · see citing works
<i>Chlamydophila (Chlamydia) pneumoniae</i>in the Alzheimer's brain
Gérard, H. C., Dreses-Werringloer, U., Wildt, K. S., Deka, S., Oszust, C., Balin, B. J., Frey, W. H., Bordayo, E. Z., Whittum-Hudson, J. A., & Hudson, A. P. (2006) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2006.00154.x · Cited by 186 · see citing works
Wu, H.-Y., & Russell, M. W. (1997) · Immunologic Research · doi:10.1007/bf02786362 · Cited by 184 · see citing works
Smith, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00422 · Cited by 168 · see citing works
Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
Hammond, C. J., Hallock, L. R., Howanski, R. J., Appelt, D. M., Little, C. S., & Balin, B. J. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-121 · Cited by 156 · see citing works
Mahoney, E. R., Dumitrescu, L., Moore, A. M., Cambronero, F. E., De Jager, P. L., Koran, M. E. I., Petyuk, V. A., Robinson, R. A. S., Goyal, S., Schneider, J. A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0458-5 · Cited by 150 · see citing works
<i>Chlamydia pneumoniae</i>Infection in Human Monocytes
Airenne, S., Surcel, H.-M., Alakärppä, H., Laitinen, K., Paavonen, J., Saikku, P., & Laurila, A. (1999) · Infection and Immunity · doi:10.1128/iai.67.3.1445-1449.1999 · Cited by 138 · see citing works
Critical review: involvement of endoplasmic reticulum stress in the aetiology of Alzheimer's disease
Hashimoto, S., & Saido, T. C. (2018) · Open Biology · doi:10.1098/rsob.180024 · Cited by 129 · see citing works
Tomlinson, A. H., & Esiri, M. M. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90158-2 · Cited by 126 · see citing works
Alasmari, F., Alshammari, M. A., Alasmari, A. F., Alanazi, W. A., & Alhazzani, K. (2018) · BioMed Research International · doi:10.1155/2018/3087475 · Cited by 125 · see citing works
Jarolim, K. L., McCosh, J. K., Howard, M. J., & John, D. T. (2000) · Journal of Parasitology · doi:10.1645/0022-3395(2000)086[0050:almsot]2.0.co;2 · Cited by 118 · see citing works
Phagocytes transmit<i>Chlamydia pneumoniae</i>from the lungs to the vasculature
Gieffers, J., van Zandbergen, G., Rupp, J., Sayk, F., Krüger, S., Ehlers, S., Solbach, W., & Maass, M. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00093304 · Cited by 109 · see citing works
Chlamydia pneumoniae and the lung
Hammerschlag, M. R. (2000) · European Respiratory Journal · doi:10.1183/09031936.00.16510010 · Cited by 106 · see citing works
Sinonasal pathophysiology of SARS‐CoV ‐2 and COVID ‐19: A systematic review of the current evidence
Gengler, I. M., Wang, J. C., Speth, M. M., & Sedaghat, A. R. (2020) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.384 · Cited by 105 · see citing works
BAG2 structure, function and involvement in disease
Qin, L., Guo, J., Zheng, Q., & Zhang, H. (2016) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-016-0020-2 · Cited by 98 · see citing works
Nazareth, L., Lineburg, K. E., Chuah, M. I., Tello Velasquez, J., Chehrehasa, F., St John, J. A., & Ekberg, J. A. K. (2015) · Journal of Comparative Neurology · doi:10.1002/cne.23694 · Cited by 96 · see citing works
Self-citationMotile membrane protrusions regulate cell–cell adhesion and migration of olfactory ensheathing glia
Windus, L. C. E., Claxton, C., Allen, C. L., Key, B., & John, J. A. S. (2007) · Glia · doi:10.1002/glia.20586 · Cited by 94 · see citing works
Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves
Perlman, S. M., Jacobsen, G., & Afifi, A. K. (1989) · Virology · doi:10.1016/0042-6822(89)90446-7 · Cited by 91 · see citing works
Amyloid-β Deposition and Olfactory Dysfunction in an Alzheimer's Disease Model
Wu, N., Rao, X., Gao, Y., Wang, J., & Xu, F. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-122443 · Cited by 89 · see citing works
Phagocytic Roles of Glial Cells in Healthy and Diseased Brains
Jung, Y.-J., & Chung, W.-S. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.133 · Cited by 89 · see citing works
Vincent, A. J., Choi‐Lundberg, D. L., Harris, J. A., West, A. K., & Chuah, M. I. (2007) · Glia · doi:10.1002/glia.20512 · Cited by 84 · see citing works
John, J. A. S., Ekberg, J. A. K., Dando, S. J., Meedeniya, A. C. B., Horton, R. E., Batzloff, M. R., Owen, S., Holt, S., Peak, I. R. A., Ulett, G. C., et al. (2014) · mBio · doi:10.1128/mbio.00025-14 · Cited by 83 · see citing works
Self-citationChlamydial Infection of Immune Cells: Altered Function and Implications for Disease
Beagley, K., Huston, W. M., Hansbro, P. M., & Timms, P. (2009) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v29.i4.10 · Cited by 81 · see citing works
Self-citationFailure To Detect <i>Chlamydia pneumoniae</i> in the Late-Onset Alzheimer's Brain
Ring, R. H., & Lyons, J. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.7.2591-2594.2000 · Cited by 81 · see citing works
Olfactory Nerve—A Novel Invasion Route of Neisseria meningitidis to Reach the Meninges
Sjölinder, H., & Jonsson, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014034 · Cited by 78 · see citing works
Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia
Balin, B. J., Hammond, C. J., Little, C. S., Hingley, S. T., Al-Atrache, Z., Appelt, D. M., Whittum-Hudson, J. A., & Hudson, A. P. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00302 · Cited by 77 · see citing works
Lanke, V., Moolamalla, S. T. R., Roy, D., & Vinod, P. K. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00153 · Cited by 76 · see citing works
Alzheimer's disease: An olfactory connection?
Mann, D. M. A., Tucker, C. M., & Yates, P. O. (1988) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(88)90058-9 · Cited by 72 · see citing works
Little, C. S., Joyce, T. A., Hammond, C. J., Matta, H., Cahn, D., Appelt, D. M., & Balin, B. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00304 · Cited by 71 · see citing works
Webley, W. C., & Hahn, D. L. (2017) · Respiratory Research · doi:10.1186/s12931-017-0584-z · Cited by 71 · see citing works
Metabolism‐Dependent Toxicity of Methimazole in the Olfactory Nasal Mucosa
Brittebo, E. B. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00107.x · Cited by 69 · see citing works
Herbert, R. P., Harris, J., Chong, K. P., Chapman, J., West, A. K., & Chuah, M. I. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-109 · Cited by 69 · see citing works
Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract
Wong, K. H., Skelton, S. K., & Chan, Y. K. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.7.1625-1630.1992 · Cited by 67 · see citing works
Olfactory glia enhance neonatal axon regeneration
Chehrehasa, F., Windus, L. C. E., Ekberg, J. A. K., Scott, S., Amaya, D. A., Mackay‐Sim, A., & John, J. A. S. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.07.002 · Cited by 66 · see citing works
Self-citationMagnetic Cell Sorting for In Vivo and In Vitro Astrocyte, Neuron, and Microglia Analysis
Holt, L. M., Stoyanof, S. T., & Olsen, M. L. (2019) · Current Protocols in Neuroscience · doi:10.1002/cpns.71 · Cited by 65 · see citing works
The role of CD2AP in the Pathogenesis of Alzheimer's Disease
Tao, Q.-Q., Chen, Y.-C., & Wu, Z.-Y. (2019) · Aging and disease · doi:10.14336/ad.2018.1025 · Cited by 61 · see citing works
Human CDK18 promotes replication stress signaling and genome stability
Barone, G., Staples, C. J., Ganesh, A., Patterson, K. W., Bryne, D. P., Myers, K. N., Patil, A. A., Eyers, C. E., Maslen, S., Skehel, J. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw615 · Cited by 59 · see citing works
Olfactory ensheathing cells: Nitric oxide production and innate immunity
Harris, J. A., West, A. K., & Chuah, M. I. (2009) · Glia · doi:10.1002/glia.20899 · Cited by 58 · see citing works
Chlamydia pneumoniae‐Mediated Inflammation in Atherosclerosis: A Meta‐Analysis
Filardo, S., Pietro, M. D., Farcomeni, A., Schiavoni, G., & Sessa, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/378658 · Cited by 57 · see citing works
Observation on the presence of Listeria monocytogenes in axons.
Otter, A., & Blakemore, W. F. (1989) · PubMed · Cited by 50 · see citing works
John, J. A. S., Walkden, H., Nazareth, L., Beagley, K. W., Ulett, G. C., Batzloff, M. R., Beacham, I. R., & Ekberg, J. A. K. (2016) · Infection and Immunity · doi:10.1128/iai.00361-16 · Cited by 49 · see citing works
Self-citationChlamydia pneumoniae infection of brain cells: An in vitro study
Boelen, E., Steinbusch, H. W. M., van der Ven, A. J. A. M., Grauls, G., Bruggeman, C. A., & Stassen, F. R. M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.014 · Cited by 46 · see citing works
HSP70-2 (HSPA1B) is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease
Clarimón, J., Bertranpetit, J., Boada, M., Tàrraga, L., & Comas, D. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703256051 · Cited by 44 · see citing works
Peralta, S., Torraco, A., Wenz, T., Garcia, S., Diaz, F., & Moraes, C. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt526 · Cited by 42 · see citing works
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Liu, H., Luo, K., & Luo, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-21256-6 · Cited by 42 · see citing works
Neurologic aspects of covid-19: a concise review.
Brouwer, M. C., Ascione, T., & Pagliano, P. (2020) · PubMed · Cited by 42 · see citing works
Macedo-Ramos, H., Campos, F. S. O., Carvalho, L. A., Ramos, I. B., Teixeira, L. M., De Souza, W., Cavalcante, L. A., & Baetas-da-Cruz, W. (2011) · Neuroscience Research · doi:10.1016/j.neures.2010.12.015 · Cited by 41 · see citing works
Boelen, E., Stassen, F. R. M., van der Ven, A. J. A. M., Lemmens, M. A. M., Steinbusch, H. P. J., Bruggeman, C. A., Schmitz, C., & Steinbusch, H. W. M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0252-3 · Cited by 41 · see citing works
THE RAPID INVASION OF THE BODY THROUGH THE OLFACTORY MUCOSA
Rake, G. W. (1937) · The Journal of Experimental Medicine · doi:10.1084/jem.65.2.303 · Cited by 39 · see citing works
Interaction of Chlamydiae with human macrophages
Herweg, J., & Rudel, T. (2016) · The FEBS Journal · doi:10.1111/febs.13609 · Cited by 39 · see citing works
Primary Intranasal Lining Injury Cause, Deformities, and Treatment Plan
Menick, F. J., & Salibian, A. (2014) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0000000000000694 · Cited by 39 · see citing works
Xie, F., Zhou, X., Genter, M. B., Behr, M., Gu, J., & Ding, X. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037895 · Cited by 37 · see citing works
Conservation of extrusion as an exit mechanism for<i>Chlamydia</i>
Zuck, M., Sherrid, A., Suchland, R., Ellis, T., & Hybiske, K. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw093 · Cited by 37 · see citing works
Al-Atrache, Z., Lopez, D. B., Hingley, S. T., & Appelt, D. M. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0489-5 · Cited by 37 · see citing works
Little, C. S., Bowe, A., Lin, R., Litsky, J., Fogel, R. M., Balin, B. J., & Fresa-Dillon, K. L. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1723-1734.2005 · Cited by 35 · see citing works
Nazareth, L., Tello Velasquez, J., Lineburg, K. E., Chehrehasa, F., St John, J. A., & Ekberg, J. A. K. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.005 · Cited by 34 · see citing works
Self-citationChlamydia and chronic arthritis
Carter, J. D., Inman, R. D., Whittum‐Hudson, J. A., & Hudson, A. P. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.606830 · Cited by 34 · see citing works
Alzheimer Cells on Their Way to Derailment Show Selective Changes in Protein Quality Control Network
Koopman, M. B., & Rüdiger, S. G. D. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00214 · Cited by 33 · see citing works
Brooks, L. R. K., & Mias, G. I. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00392 · Cited by 32 · see citing works
Ou-Yang, M.-H., & Van Nostrand, W. E. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-134 · Cited by 30 · see citing works
Dreses‐Werringloer, U., Gérard, H. C., Whittum‐Hudson, J. A., & Hudson, A. P. (2006) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200610000-00003 · Cited by 26 · see citing works
Axl receptor tyrosine kinase is a regulator of apolipoprotein E
Zhao, W., Fan, J., Kulic, I., Koh, C., Clark, A., Meuller, J., Engkvist, O., Barichievy, S., Raynoschek, C., Hicks, R., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-00609-1 · Cited by 25 · see citing works
Novel insights into the glia limitans of the olfactory nervous system
Nazareth, L., Chen, M., Shelper, T., Shah, M., Tello Velasquez, J., Walkden, H., Beacham, I., Batzloff, M., Rayfield, A., Todorovic, M., et al. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24618 · Cited by 24 · see citing works
Self-citationWalkden, H., Delbaz, A., Nazareth, L., Batzloff, M., Shelper, T., Beacham, I. R., Chacko, A., Shah, M., Beagley, K. W., Tello Velasquez, J., et al. (2020) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0008017 · Cited by 21 · see citing works
Self-citationIkejima, H., Friedman, H. P., & Yamamoto, Y. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46348-0 · Cited by 20 · see citing works
Roberts, R. O., Kang, Y. N., Hu, C., Moser, C. D., Wang, S., Moore, M. J., Graham, R. P., Lai, J.-P., Petersen, R. C., & Roberts, L. R. (2017) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170028 · Cited by 19 · see citing works
Delbaz, A., Chen, M., Jen, F. E.-C., Schulz, B. L., Gorse, A.-D., Jennings, M. P., St John, J. A., & Ekberg, J. A. K. (2020) · Infection and Immunity · doi:10.1128/iai.00955-19 · Cited by 18 · see citing works
Self-citation(1999) · PubMed · Cited by 17 · see citing works
Furrows, S. J., Hartley, J. C., Bell, J. E., Silver, N., Losseff, N. A., Stevenson, S., Chapman, M. D., Thompson, E. J., Ridgway, G. L., & Giovannoni, G. (2004) · PubMed Central · Cited by 17 · see citing works
Dando, S. J., Ipe, D. S., Batzloff, M. R., Sullivan, M. J., Crossman, D. K., Crowley, M., Strong, E. J., Kyan, S., Leclercq, S. Y., Ekberg, J. A. K., et al. (2016) · Infection and Immunity · doi:10.1128/iai.01546-15 · Cited by 17 · see citing works
Self-citationInflammatory responses following Chlamydia pneumoniae infection of glial cells
Boelen, E., Steinbusch, H. W. M., Pronk, I., Grauls, G., Rennert, P. D., Bailly, V., Bruggeman, C. A., & Stassen, F. R. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05339.x · Cited by 14 · see citing works
Nazareth, L., Walkden, H., Chacko, A., Delbaz, A., Shelper, T., Armitage, C. W., Reshamwala, R., Trim, L. K., St John, J. A., Beagley, K. W., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.607779 · Cited by 12 · see citing works
Self-citationArmitage, C. W., O'Meara, C. P., & Beagley, K. W. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12295 · Cited by 8 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Little, C. S. et al. Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front. Aging Neurosci. 6, 304. https://doi.org/10.3389/fnagi.2014.00304 (2014). · DOI · Paper page
- Ries, M. & Sastre, M. Mechanisms of Aβ clearance and degradation by glial cells. Front. Aging Neurosci. https://doi.org/10.3389/fnagi.2016.00160 (2016). · DOI · Paper page
Cited by
Sorted by citations
Current understanding of the Alzheimer’s disease-associated microbiome and therapeutic strategies
Seo, D.-O., & Holtzman, D. M. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01146-2 · Cited by 249 · see citing works
The endotoxin hypothesis of Alzheimer’s disease
Brown, G. C., & Heneka, M. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00722-y · Cited by 140 · see citing works
Wang, W., Wang, Y., Wang, Y., Xie, G., Liu, S., Li, Z., Wang, P., Liu, J., & Li, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155518 · Cited by 107 · see citing works
Rao, R. V., Subramaniam, K. G., Gregory, J., Bredesen, A. L., Coward, C., Okada, S., Kelly, L., & Bredesen, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021659 · Cited by 105 · see citing works
Tan, S., Chen, W., Kong, G., Wei, L., & Xie, Y. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1305790 · Cited by 63 · see citing works
Ha, J. Y., Seok, J., Kim, S., Jung, H.-J., Ryu, K., Nakamura, M., Jang, I., Hong, S., Lee, Y., & Lee, H. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011743 · Cited by 48 · see citing works
Olfactory immunology: the missing piece in airway and CNS defence
Wellford, S. A., & Moseman, E. A. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00972-9 · Cited by 49 · see citing works
Liu, P., Chen, W., Kang, Y., Wang, C., Wang, X., Liu, W., Hayashi, T., Qiu, Z., Mizuno, K., Hattori, S., et al. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109691 · Cited by 44 · see citing works
Grayson, J. M., Short, S. M., Lee, C.-J., Park, N., Marsac, C., Sette, A., Arlehamn, C. S. L., Leng, X., Lockhart, S. N., & Craft, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-42708-8 · Cited by 36 · see citing works
The menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases
Elkins, M., Jain, N., & Tükel, Ç. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102473 · Cited by 32 · see citing works
Srivastava, P., & Kim, K.-S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112370 · Cited by 30 · see citing works
Moné, Y., Earl, J. P., Król, J. E., Ahmed, A., Sen, B., Ehrlich, G. D., & Lapides, J. R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1123228 · Cited by 28 · see citing works
Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review
Kettunen, P., Koıstınaho, J., & Rõlova, T. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03139-y · Cited by 25 · see citing works
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's disease
Barrera-Ocampo, A. A. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.03.034 · Cited by 27 · see citing works
Do microbes play a role in Alzheimer's disease?
Williams, Z. A. P., Láng, L., Nicolas, S., Clarke, G. A., Cryan, J. F., Vauzour, D., & Nolan, Y. M. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14462 · Cited by 20 · see citing works
Chlamydia pneumoniae in Alzheimer's disease pathology
Subedi, L., Gaire, B. P., Koronyo, Y., Koronyo‐Hamaoui, M., & Crother, T. R. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1393293 · Cited by 23 · see citing works
Zhai, Z., Huang, Y., Zhang, Y., Zhao, L., & Li, W. (2022) · Antioxidants · doi:10.3390/antiox11081564 · Cited by 20 · see citing works
Cutuli, D., Giacovazzo, G., Decandia, D., & Coccurello, R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1010169 · Cited by 16 · see citing works
Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota
Wang, J., Zhu, X., Li, Y., Guo, W., & Li, M. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4023006 · Cited by 17 · see citing works
Yan, R., Wang, W., Yang, W., Huang, M., & Xu, W. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230314 · Cited by 17 · see citing works
Gaire, B. P., Koronyo, Y., Vit, J., Hutton, A., Subedi, L., Fuchs, D.-T. S., Swerdlow, N., Rentsendorj, A., Shahin, S., Martinon, D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68580-4 · Cited by 16 · see citing works
Hosseininasab, S.-S.-M., Ebrahimi, R., Yaghoobpoor, S., Kazemi, K., Khakpour, Y., Hajibeygi, R., Mohamadkhani, A., Fathi, M., Vakili, K., Tavasol, A., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1513095 · Cited by 18 · see citing works
Zhou, X., Kumar, P., Bhuyan, D. J., Jensen, S. O., Roberts, T. L., & Münch, G. W. (2023) · Biomolecules · doi:10.3390/biom13111568 · Cited by 15 · see citing works
Roberts, J. A., Elkind, M. S. V., Liu, M., Wright, C. B., Rundek, T., & Gutierrez, J. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120856 · Cited by 13 · see citing works
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease
Bathini, P., Brai, E., Balin, B. J., Bimler, L. H., Corry, D. B., Devanand, D. P., Doty, R. L., Ehrlich, G. D., Eimer, W. A., Fülöp, T., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae328 · Cited by 13 · see citing works
Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1467333 · Cited by 11 · see citing works
Wang, J., Yu, N., Wang, D.-Z., Guo, L., Yang, S., Zheng, B., Guo, F., & Wang, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221112 · Cited by 10 · see citing works
Chlamydia pneumonia infection and risk of multiple sclerosis: A meta-analysis
Arjmandi, D., Graeili, Z., Mohammadi, P., Arshadi, M., Tadi, M. J., Ardekani, A., Naeimi, R., Abbasi, F., Marhoommirzabak, E., Mahjour, S., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104862 · Cited by 9 · see citing works
Zeng, Y., Cao, S., Pang, K., Tang, J., & Lin, G. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230954 · Cited by 8 · see citing works
Pal, S., Slepenkin, A., Felgner, J. H., Davies, D. H., Felgner, P. L., & de la Maza, L. M. (2023) · Pathogens · doi:10.3390/pathogens12070863 · Cited by 7 · see citing works
Zhang, L., Wang, D.-Z., Wang, J., Guo, L., Li, B.-H., & Wang, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230007 · Cited by 6 · see citing works
Kordi, R., Andrews, T. J., & Hicar, M. D. (2025) · Virology · doi:10.1016/j.virol.2025.110523 · Cited by 6 · see citing works
Maheshwari, K., Gupta, R., Sharma, R., Kaur, A., Vashist, A., & Aggarwal, G. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2391488 · Cited by 6 · see citing works
Circulating Chlamydia Trachomatis Antigens in Subjects With Alzheimer’s Disease
Lehrer, S. P., & Rheinstein, P. H. (2022) · In Vivo · doi:10.21873/invivo.12999 · Cited by 5 · see citing works
Biswal, B., Satapathy, B. S., Mishra, A., Maharana, L., & Pattnaik, S. (2025) · Current Drug Discovery Technologies · doi:10.2174/0115701638329824241220055621 · Cited by 4 · see citing works
Quantification of inhaled cigarette smoke movement and deposition in human nasal airways
Wang, Y., Yang, F., Li, C., Ma, R., Li, Z., Chen, X., Cheng, S., Gong, M., Lou, M., Hu, Z., et al. (2025) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2025.106548 · Cited by 4 · see citing works
Infections with Chlamydia pneumoniae and SARS-CoV-2 and Alzheimer’s disease pathogenesis
Romanella, A., McCall, M., Corwin, R., Faruq, A. A., Lingo, E. G., Bhambhani, S., Hammond, C. J., & Balin, B. J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1587782 · Cited by 4 · see citing works
Exploring the role of multi-pathogen infections in Alzheimer’s disease: A case–control study
García-Bustos, V., Cabañero-Navalón, M. D., Lloret-Sos, C., Gómez, M., Baquero, M., Ibanez-Barcelo, S., Grimaldos, J., & Cháfer-Pericás, C. (2025) · Virulence · doi:10.1080/21505594.2025.2560904 · Cited by 4 · see citing works
Chlamydia Infection’s Role in Neurological Diseases
Uzun, N. (2023) · Infectious diseases · doi:10.5772/intechopen.110842 · Cited by 4 · see citing works
Smoking Impacts Alzheimer’s Disease Progression Through Oral Microbiota Modulation
Dai, X., Liang, R., Dai, M., Li, X., & Zhao, W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04241-1 · Cited by 4 · see citing works
Zeiher, C., Kuhrt, H., Rifflet, A., Winter, K., Boon, L., Stassart, R. M., Nutma, E., Middeldorp, J., Strating, I. M., Boneca, I. G., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.024 · Cited by 4 · see citing works
The Chlamydia pneumoniae inclusion membrane protein Cpn0308 interacts with host protein ACBD3
Ma, L., Jia, X., Gao, Z., Zhou, Y., Cheng, Y., Li, P., & Jia, T. (2024) · Journal of Bacteriology · doi:10.1128/jb.00275-24 · Cited by 3 · see citing works
Tracking Chlamydia – Host interactions and antichlamydial activity in Caenorhabditis elegans
Reigada, I., Kapp, K., Kaudela, T., Soria, M. G., Oksanen, T., & Hanski, L. L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116956 · Cited by 3 · see citing works
Proteomic scrutiny of nasal microbiomes: implications for the clinic
Zhu, K., Jin, Y., Zhao, Y., He, A., Wang, R., & Cao, C. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2323983 · Cited by 2 · see citing works
Hippocampal syndrome secondary to tuberculosis: From neuroinflammation to neurodegeneration
Torres, J. C. M., Durán-Hernández, N., Choreño-Parra, J. A., Sánchez-Garibay, C., & Salinas‐Lara, C. (2025) · Tuberculosis · doi:10.1016/j.tube.2025.102653 · Cited by 2 · see citing works
Rangel, G. A., Muñoz, B. A., Ramirez, M., Wroblewski, K., Villarreal, A. E., Oviedo, D. C., Carreira, M. B., McLeod, R. L., & Britton, G. B. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251361066 · Cited by 2 · see citing works
Duan, X., Wang, F., Liu, W., Xie, Y., Yang, M., Ping, Y., Pan, Y., Wei, Z., Li, H., Zhang, Q.-P., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13346-z · Cited by 4 · see citing works
Infection, Neuroinflammation and Interventions for Healthy Brain and Longevity
Fülöp, T., Ramassamy, C., Lacombe, G., Frost, E. H., Cohen, A. A., Rodrigues, S., Desroches, M., Hirokawa, K., Laurent, B., & Witkowski, J. M. (2024) · Healthy ageing and longevity · doi:10.1007/978-3-031-68513-2_12 · Cited by 2 · see citing works
Precision medicine for brain health and prevention of neurodegenerative/neurocognitive decline
Hausman-Cohen, S., & Bilich, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-98808-7.00011-4 · Cited by 1 · see citing works
Shi, X., Zhu, X., Zhang, H., Wang, Y., Qi, X., Cheng, F., Xu, D., Wang, L., Duan, H., & Zhao, C. (2025) · Journal of Asthma and Allergy · doi:10.2147/jaa.s509434 · Cited by 1 · see citing works
Li, Z. J., Yang, S., & Su, L. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091175 · Cited by 1 · see citing works
Delbaz, A., & John, J. A. S. (2026) · Cells · doi:10.3390/cells15080690 · Cited by 2 · see citing works
Self-citationThe impact of microbiological infections on neurodegenerative diseases
Dilawari, R., & Singh, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00016-7 · Cited by 1 · see citing works
(2022) · BJPsych International · doi:10.1192/bji.2022.8
Singh, P., Kaushik, M., Gupta, S. K., & Chaudhary, A. (2024) · Journal of Applied Biology & Biotechnology · doi:10.7324/jabb.2024.176869
Pathogens Association with Alzheimer Disease: Emerging Concepts and New Perspectives
Agarwal, U., Tonk, R. K., & Verma, S. K. (2025) · Current Gene Therapy · doi:10.2174/0115665232389348250722073721
Clinical and Morphological Characteristics of Chlamydial Infections in Humans
Zinserling, V. A., Poznyak, A. L., Sidorchuk, S., & Wassilew, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-99642-9_5
Problems of Mixed Chlamydial Infections
Zinserling, V. A., Poznyak, A. L., Sidorchuk, S., & Wassilew, K. (2025) · Springer eBooks · doi:10.1007/978-3-031-99642-9_7
Zou, J., Liao, R., Zhang, W., & Kuang, Z. (2025) · Brain Sciences · doi:10.3390/brainsci15101076
Beyond association: A quantitative analysis of the infectious burden in Alzheimer's disease
Bender, Ö., Shemesh, O. A., & Bar, D. Z. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261447530
Association between Toxoplasma gondii seropositivity and Alzheimer’s disease: a case-control study
Aldaghi, M., Khatir, A. A., Sepidarkish, M., Arjmandi, D., Mousavi, F., Aghapour, S., Bayani, M., & Rostami, A. (2026) · Parasitology Research · doi:10.1007/s00436-026-08711-4
The evolutionary origins of dementia
Stone, J. A., Johnstone, D. M., Mason, R. S., Mitrofanis, J., & Robinson, S. R. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261470053
Kumar, N., & Yarlagadda, V. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00255
Exploring the role of infectious pathogens in Alzheimer’s disease neuroinflammation
Vaiasicca, S., Mangiaterra, G., Citterio, B., Piccioni, G., Orlando, F., Giorgetti, B., Cianfruglia, L., Giacconi, R., Fumarola, S., Cardelli, M., et al. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1919289
Kuikel, K., McEwen, A., Mathiske, T. J., Wojtaszak, L., John, J. A. S., & Delbaz, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198820
Self-citation
- Authors
- Chacko, A., Delbaz, A., Walkden, H., Basu, S., Armitage, C. W., Eindorf, T., Trim, L. K., Miller, E., West, N. P., St John, J. A., Beagley, K. W., & Ekberg, J. A. K.
- Affiliations
- Griffith University (AU)
- King's College London (GB)
- Queensland University of Technology (AU)
- Corresponding author
- Ekberg, Jenny A. K.
- ORCID
- Venue
- Scientific Reports
- Published
- 2022-02-17
- Volume
- 12
- Issue
- 1
- Pages
- 2759-2759
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC8854390
- OpenAlex
- W4212965440
- Cited by
- 65
- References
- 93
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 21 · 2023: 15 · 2022: 6
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- QUT ePrints (Queensland University of Technology) (submittedVersion)
- Griffith Research Online (submittedVersion, cc-by)
- Funders
- Menzies Health Institute Queensland Capacity Grant
- Griffith University International postgraduate research scholarship
- Goda Foundation Grant
- Clem Jones Foundation Grant
- ARC Discovery Grant (DP150104495)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Chlamydia pneumoniae, central nervous system infection, olfactory nerve, trigeminal nerve, olfactory bulb, Alzheimer's disease, amyloid-beta deposition, late-onset dementia, neuroinvasion, intranasal infection, mouse model
- MeSH terms
- Alzheimer Disease, Animals, Female, Mice, Inbred BALB C, Olfactory Nerve, Trigeminal Nerve, Chlamydophila pneumoniae, Chlamydophila Infections, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review